Processing 00000000.tx.1: Physiological and Pathological Changes in Glucose Regulate Brain Akt and Glycogen Synthase Kinase-3* Buffie Clodfelder-Miller, Patrizia De Sarno, Anna A. 

Phrase: "Physiological"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205463:Physiological [Functional Concept]
   928 E C0031842:Physiology [Biomedical Occupation or Discipline]
   928 E C0031843:physiology [Physiologic Function]

Phrase: "and"

Phrase: "Pathological Changes in Glucose"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "Regulate"

Phrase: "Brain Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "Glycogen Synthase Kinase-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "* Buffie Clodfelder-Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0402830:Miller [Professional or Occupational Group]

Phrase: "Patrizia De Sarno,"

Phrase: "Anna A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]
Processing 00000000.tx.2: Zmijewska, Ling Song, and Richard S. 

Phrase: "Zmijewska,"

Phrase: "Ling Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0872005:Song [Intellectual Product]

Phrase: "and"

Phrase: "Richard S."
Processing 00000000.tx.3: Jope1 From the Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama 35294-0017 Received for publication, August 10, 2005  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Insulin regulates the phosphorylation and activities of Akt and glycogen synthase kinase-3 (GSK3) in peripheral tissues, but in the brain it is less clear how this signaling pathway is regulated in vivo and whether it is affected by diabetes. 

Phrase: "Jope1 From the Department of Psychiatry"

Phrase: "and"

Phrase: "Behavioral Neurobiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027817:Neurobiology [Biomedical Occupation or Discipline]

Phrase: "University of Alabama at Birmingham,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0001895:Alabama [Geographic Area]
   760   C0041740:University [Manufactured Object,Organization]
   760   C1551894:Alabama [Language]
   760   C2825084:Alabama [Eukaryote]

Phrase: "Birmingham,"

Phrase: "Alabama 35294-0017"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0001895:Alabama [Geographic Area]
   827   C1551894:Alabama [Language]
   827   C2825084:Alabama [Eukaryote]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "August 10,"

Phrase: "2005  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "the phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "activities of Akt"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441655:Activities [Activity]
   756 E C0205177:Activity [Functional Concept]
   756 E C0439167:% activity [Quantitative Concept]
   756 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "glycogen synthase kinase-3 (GSK3) in peripheral tissues,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but in the brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "it"

Phrase: "is"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "how"

Phrase: "this signaling pathway"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0037083:signaling pathway [Cell Function]
  1000   C0086982:Signaling Pathway [Molecular Function]
   983 E C0037080:Signal Pathway [Molecular Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "whether"

Phrase: "it"

Phrase: "is"

Phrase: "affected by diabetes."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]
Processing 00000000.tx.4: We found that Akt and GSK3 are sensitive to glucose, because fasting decreased and glucose administration increased by severalfold the phosphorylation of Akt and GSK3 in the cerebral cortex and hippocampus of non-diabetic mice. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "sensitive to glucose,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332324:Sensitive to [Functional Concept]
           Sensitive
   790   C1550474:sensitive [Idea or Concept]

Phrase: "because"

Phrase: "fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "glucose administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001554:Administration [Occupational Activity]
   861   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "increased by severalfold"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "the phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "GSK3 in the cerebral cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "hippocampus of non-diabetic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C1523990:Mouse Hippocampus [Tissue]
   760   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   760   C0949582:Hippocampus [Fish]
   760   C1029104:Hippocampus [Fish]
   760   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.5: Brain Akt and GSK3 phosphorylation also increased after streptozotocin administration (3 days), which increased blood glucose and depleted blood insulin, indicating regulation by glucose availability even with deficient insulin. 

Phrase: "Brain Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3 phosphorylation also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0031715:Phosphorylation [Molecular Function]
   799   C1158886:Phosphorylation [Molecular Function]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "increased after streptozotocin administration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0001554:Administration [Occupational Activity]
   770   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "(3 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442459:3 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "depleted blood insulin,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0853230:blood insulin [Laboratory Procedure]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "indicating"

Phrase: "regulation by glucose availability even"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "with deficient insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.6: Changes in Akt and GSK3 phosphorylation and activities in epididymal fat were opposite to those of brain after streptozotocin treatment. 

Phrase: "Changes in Akt"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "GSK3 phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "activities in epididymal fat"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441655:Activities [Activity]
   737 E C0205177:Activity [Functional Concept]
   737 E C0439167:% activity [Quantitative Concept]
   737 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "opposite to those of brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521805:Opposite [Spatial Concept]

Phrase: "after streptozotocin treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.7: Streptozotocin-induced hyperglycemia and increased brain Akt and GSK3 phosphorylation were reversed by lowering blood glucose with insulin administration. 

Phrase: "Streptozotocin-induced hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "increased brain Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3 phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "reversed by lowering blood glucose"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0005802:Blood Glucose [Carbohydrate]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0229664:Blood [Body Substance]
   760   C0441994:lowering [Spatial Concept]
   760   C2003888:Lowering [Activity]
   726 E C1548802:Lower [Body Location or Region]
   726   C1555029:Reverse [Idea or Concept]

Phrase: "with insulin administration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0199782:insulin administration [Therapeutic or Preventive Procedure]
   861   C0001554:Administration [Occupational Activity]
   861   C1533734:Administration [Therapeutic or Preventive Procedure]
Processing 00000000.tx.8: Long term hyperglycemia also increased brain Akt and GSK3 phosphorylation, both 4 weeks after streptozotocin and in db/db insulin-resistant mice. 

Phrase: "Long term hyperglycemia also increased brain Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3 phosphorylation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "both 4 weeks after streptozotocin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439230:weeks [Temporal Concept]
   726 E C0332174:/week [Temporal Concept]

Phrase: "and in db/db insulin-resistant mice."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0332325:Resistant [Functional Concept]
   748   C1515981:And [Idea or Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C2827757:RESISTANT [Laboratory or Test Result]
Processing 00000000.tx.9: Thus, the Akt-GSK3 signaling pathway is regulated in mouse brain in vivo in response to physiological and pathological changes in insulin and glucose.  

Phrase: "Thus,"

Phrase: "the Akt-GSK3 signaling pathway"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   900   C1515844:AKT Signaling Pathway [Molecular Function]
   818   C0037083:signaling pathway [Cell Function]
   818   C0086982:Signaling Pathway [Molecular Function]
   801 E C0037080:Signal Pathway [Molecular Function]
   795   C1704259:Pathway [Molecular Function]
   795   C1705987:Pathway [Conceptual Entity]
   710   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "regulated in mouse brain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1521713:Mouse Brain [Tissue]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "in vivo in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "to physiological"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205463:Physiological [Functional Concept]
   928 E C0031842:Physiology [Biomedical Occupation or Discipline]
   928 E C0031843:physiology [Physiologic Function]

Phrase: "and"

Phrase: "pathological changes in insulin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.10: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Insulin resistance and diabetes represent increasingly prevalent conditions that involve impaired regulation of glucose production and utilization (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "increasingly prevalent conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "that"

Phrase: "involve"

Phrase: "impaired regulation of glucose production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042153:utilization [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.11: Recently much has been learned about insulin resistance in insulin-sensitive peripheral tissues, such as fat and skeletal muscle (2, 3). 

Phrase: "Recently much"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332185:Recently [Temporal Concept]

Phrase: "has"

Phrase: "been"

Phrase: "learned about insulin resistance"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0023185:learned [Mental Process]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in insulin-sensitive peripheral tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0040300:Tissues [Tissue]
   779 E C1547928:Tissue [Intellectual Product]

Phrase: "such as fat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0424612:FAT [Organism Attribute]

Phrase: "and"

Phrase: "skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: In contrast, little is understood about diabetes-induced changes in insulin-linked signaling activities in the brain even though cognition is often impaired in diabetic subjects (4), and the brain accounts for 20% of the energy utilization in the body of adult humans (5). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "understood about diabetes-induced changes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0205263:Induced [Functional Concept]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726   C0162340:Understand [Mental Process]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "in insulin-linked signaling activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   886   C1145751:insulin activity [Molecular Function]
   812   C0441655:Activities [Activity]
   779 E C0205177:Activity [Functional Concept]
   779 E C0439167:% activity [Quantitative Concept]
   779 E C1561536:*Activity [Idea or Concept]

Phrase: "in the brain even"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "though"

Phrase: "cognition"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009240:Cognition [Mental Process]
   916 E C2981149:Intellect [Mental Process]
   907 E C0233698:Noesis [Mental or Behavioral Dysfunction]

Phrase: "is"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "impaired in diabetic subjects"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0221099:Impaired [Functional Concept]
   770   C0241863:DIABETIC [Finding]
   770   C0684336:Impaired [Pathologic Function]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "(4"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "accounts for 20% of the energy utilization"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0042153:utilization [Functional Concept]
   748   C0424589:Energy [Finding]
   748   C0542479:Energy [Natural Phenomenon or Process]
   748   C1442080:Energy [Quantitative Concept]
   748   C1551359:account [Idea or Concept]
   748   C2741673:Account # [Clinical Attribute]
   748   C2981730:Account [Classification]

Phrase: "in the body"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242821:body [Human]
  1000   C0460148:Body [Anatomical Structure]
  1000   C1268086:Body [Anatomical Structure]
   916 E C1995017:Bodies [Cell Component]

Phrase: "of adult humans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0001675:Human, Adult [Age Group]
   861   C0086418:Humans [Human]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.13: Glucose is the predominant substrate of the brain, and its consumption is tightly linked to neuronal activity, leaving neuronal function highly dependent on a continual supply of glucose (6). 

Phrase: "Glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "is"

Phrase: "the predominant substrate of the brain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "its consumption"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009830:Consumption [Activity]
  1000   C1947907:Consumption [Physiologic Function]

Phrase: "is"

Phrase: "tightly"

Phrase: "linked to neuronal activity,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1561536:*Activity [Idea or Concept]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "leaving"

Phrase: "neuronal function"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0031843:function [Physiologic Function]
   861   C0521390:Neuronal [Immunologic Factor]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0027882:Neuron [Cell]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "highly dependent on a continual supply of glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.14: Because of this high demand for glucose, neurons have developed energy-efficient designs (7) and specialized glucose uptake mechanisms (8) to ensure adequate supply even at times when circulating glucose levels are low. 

Phrase: "Because of this high demand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441516:Demand [Therapeutic or Preventive Procedure]
   861   C0699784:demand [Idea or Concept]

Phrase: "for glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "have"

Phrase: "developed energy-efficient designs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1707689:Design [Activity]
   779   C2983265:DESIGN [Intellectual Product]

Phrase: "(7"

Phrase: ")"

Phrase: "and"

Phrase: "specialized glucose uptake mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0441712:Mechanisms [Functional Concept]
   779 E C1706376:Mechanism [Manufactured Object]

Phrase: "(8"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "adequate supply even at times"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243163:supply [Idea or Concept]
   760   C0699914:supply [Quantitative Concept]
   760   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   760   C1561604:supply [Functional Concept]
   760   C1875802:SUPPLY [Medical Device]
   760   C1999230:Supply [Activity]

Phrase: "when"

Phrase: "circulating glucose levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "low."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]
Processing 00000000.tx.15: Incumbent upon a system relying almost exclusively on glucose are mechanisms to sense and respond to fluctuations in the level of glucose, such as the well known regulation of blood flow by the brain that constricts or dilates arterioles to regulate local blood flow in accordance with demands of neuronal activity (9, 10). 

Phrase: "Incumbent upon a system relying almost exclusively"

Phrase: "on glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "are"

Phrase: "mechanisms to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: "and"

Phrase: "respond to fluctuations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0231239:fluctuations [Sign or Symptom]
   756 E C0231241:Fluctuation [Temporal Concept]
   756 E C2827773:Fluctuation% [Qualitative Concept]

Phrase: "in the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "such as the well known regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]

Phrase: "of blood flow"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0232338:Blood flow [Organism Function]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   861   C0806140:Flow [Natural Phenomenon or Process]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "by the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "that"

Phrase: "constricts"

Phrase: "or"

Phrase: "dilates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700124:Dilate [Functional Concept]

Phrase: "arterioles to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003847:Arterioles [Body Part, Organ, or Organ Component]
   827 E C1282826:Arteriole [Body Part, Organ, or Organ Component]

Phrase: "regulate"

Phrase: "local blood flow in accordance with demands of neuronal activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0232338:Blood flow [Organism Function]
   739   C0005767:Blood [Tissue]
   739   C0005768:blood [Body Substance]
   739   C0229664:Blood [Body Substance]
   739   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.16: However, the brain is largely insulated from changes of insulin in the blood (11), so little is known about how insulin-coupled signaling systems within the brain either sense, or respond to, fluctuations in the circulating level of glucose or if they are buffered from such fluctuations. 

Phrase: "However,"

Phrase: "the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "largely"

Phrase: "insulated from changes of insulin"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C1705241:Change [Quantitative Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in the blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "so"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "about how insulin-coupled signaling systems within the brain either sense,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   704   C0449913:System [Functional Concept]
   704   C1553451:System [Manufactured Object]
   704   C1704459:System [Medical Device]

Phrase: "or"

Phrase: "respond"

Phrase: "to,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "fluctuations in the circulating level of glucose"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0231239:fluctuations [Sign or Symptom]
   714 E C0231241:Fluctuation [Temporal Concept]
   714 E C2827773:Fluctuation% [Qualitative Concept]

Phrase: "or"

Phrase: "if"

Phrase: "they"

Phrase: "are"

Phrase: "buffered from such fluctuations."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0231239:fluctuations [Sign or Symptom]
   737 E C0231241:Fluctuation [Temporal Concept]
   737 E C2827773:Fluctuation% [Qualitative Concept]
Processing 00000000.tx.17: Insulin receptors in virtually all vertebrate tissues, including the brain, are coupled to the prominent signaling pathway encompassing Akt (also known as protein kinase B) and glycogen synthase kinase-3 (GSK3).2 In insulin-responsive tissues, insulin signaling activates Akt, which inactivates GSK3 (12). 

Phrase: "Insulin receptors in virtually"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   799 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "all vertebrate tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "coupled to the prominent signaling pathway encompassing Akt"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   793   C1515844:AKT Signaling Pathway [Molecular Function]
   770   C0037083:signaling pathway [Cell Function]
           Signaling
   770   C0086982:Signaling Pathway [Molecular Function]
   767 E C0037080:pathway signaling [Molecular Function]
   744   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205402:Prominent [Qualitative Concept]
   744   C0812228:AKT [Gene or Genome]
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]
   744   C1948027:Coupled [Functional Concept]
   744   C3537152:signaling [Biologic Function]
   711 E C0010222:couple [Family Group]
   711 E C1710082:Signal [Phenomenon or Process]

Phrase: "(also"

Phrase: "known as protein kinase B"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0164786:Protein Kinase B [Amino Acid, Peptide, or Protein,Enzyme]
   862   C0285558:Protein Kinase B [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0377800:protein B [Amino Acid, Peptide, or Protein,Receptor]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205309:Known [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "glycogen synthase kinase-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ").2 In insulin-responsive tissues,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0040300:Tissues [Tissue]
   760   C0205342:Responsive [Functional Concept]
   760   C0740116:+2 [Quantitative Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2827735:2+ [Quantitative Concept]
   760   C2981700:2+ [Classification]
   726 E C1547928:Tissue [Intellectual Product]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "insulin signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Akt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "which"

Phrase: "inactivates"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.18: Akt is activated by dual phosphorylation on threonine 308 and serine 473 carried out by 3-phosphoinositide-dependent kinase-1 (PDK1) and an unidentified kinase often called PDK2, respectively (13). 

Phrase: "Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "is"

Phrase: "activated by dual phosphorylation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]
   770   C1554184:Dual [Intellectual Product]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "on threonine 308"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "serine 473"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out by 3-phosphoinositide-dependent kinase-1 (PDK1)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0089793:Phosphoinositide Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031621:phosphoinositide [Biologically Active Substance,Lipid]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0439787:Out [Spatial Concept]
   748   C0849355:Out [Qualitative Concept]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "an unidentified kinase often called PDK2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1150639:PDK2 [Molecular Function]
   804   C1418441:PDK2 [Gene or Genome]

Phrase: "respectively"

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.19: Conversely, the activity of GSK3 is inhibited by N-terminal serine phosphorylation of the two GSK3 isoforms, serine 9 in GSK3 and serine 21 in GSK3. 

Phrase: "Conversely,"

Phrase: "the activity of GSK3"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   879   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   840   C2261482:glycogen synthase kinase activity [Molecular Function]
   804   C1152133:glycogen synthase activity [Molecular Function]
   774   C1150423:kinase activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "inhibited by N-terminal serine phosphorylation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0205088:Terminal [Temporal Concept]
   753   C0311403:Inhibited [Qualitative Concept]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]

Phrase: "of the two GSK3 isoforms,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "serine 9 in GSK3"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0072402:Serine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "serine 21 in GSK3."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0072402:Serine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.20: Akt often appears to be the predominant kinase mediating this phosphorylation of GSK3, although this serine phosphorylation of GSK3 can be carried out by several other kinases under certain circumstances (14). 

Phrase: "Akt often"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the predominant kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "this phosphorylation of GSK3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "although"

Phrase: "this serine phosphorylation of GSK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "can"

Phrase: "be"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out by several"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]

Phrase: "other kinases under certain circumstances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.21: This coupling of Akt and GSK3 leads to inverse changes in their activities; 

Phrase: "This coupling of Akt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1948027:Coupling [Functional Concept]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "leads to inverse changes"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0392747:changes [Functional Concept]
   770   C0439850:Inverse [Qualitative Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in their activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441655:Activities [Activity]
   966 E C0205177:Activity [Functional Concept]
   966 E C0439167:% activity [Quantitative Concept]
   966 E C1561536:*Activity [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.22: when Akt activity is high it maintains GSK3 in a serine-phosphorylated inhibited state, and decreases in Akt activity lead to dephosphorylation and activation of GSK3. 

Phrase: "when"

Phrase: "Akt activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "it"

Phrase: "maintains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "GSK3 in a serine-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   831   C0033640:Glycogen synthase a kinase [Amino Acid, Peptide, or Protein,Enzyme]
   831   C1417673:glycogen synthase A kinase [Gene or Genome]
   831   C3537353:Glycogen Synthase A Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0072402:Serine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphorylated"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "state,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1301808:State [Geographic Area]
  1000   C1442792:State [Functional Concept]
  1000   C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "decreases in Akt activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205177:Activity [Functional Concept]
   770   C0392756:Decrease [Qualitative Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C0547047:Decrease [Quantitative Concept]
   770   C0812228:AKT [Gene or Genome]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "lead to dephosphorylation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C1158884:Dephosphorylation [Molecular Function]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3160734:Dephosphorylation [Molecular Function]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "activation of GSK3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1879547:Activation [Activity]
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.23: Thus insulin causes increases in the phosphorylation states of both Akt and GSK3, and in peripheral tissues such as epididymal fat and skeletal muscle these kinases can become dephosphorylated by insulin resistance and diabetes (2, 3). 

Phrase: "Thus insulin causes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015127:causes [Functional Concept]
   827   C1314792:Causes [Functional Concept]
   793 E C1524003:Cause [Conceptual Entity]

Phrase: "increases in the phosphorylation states of both Akt"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0442805:Increase [Functional Concept]
   744   C0812228:AKT [Gene or Genome]
   744   C1158886:Phosphorylation [Molecular Function]
   744   C1301808:states [Geographic Area]
   711 E C1442792:State [Functional Concept]
   711 E C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and in peripheral tissues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0040300:Tissues [Tissue]
   770   C0205100:Peripheral [Spatial Concept]
   770   C1515981:And [Idea or Concept]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "such as epididymal fat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0424612:FAT [Organism Attribute]

Phrase: "and"

Phrase: "skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "these kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "can"

Phrase: "become"

Phrase: "dephosphorylated by insulin resistance"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.24: The brain is considered to be largely buffered from detrimental effects of glucose fluctuations by efficient insulin-independent glucose transporters and utilization mechanisms (8, 15). 

Phrase: "The brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "largely"

Phrase: "buffered from detrimental effects of glucose fluctuations"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   757   C1158774:glucose effect [Genetic Function]
   748   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0231239:fluctuations [Sign or Symptom]
   748   C1280500:effects [Qualitative Concept]
   714 E C0231241:Fluctuation [Temporal Concept]
   714 E C2348382:Effect [Qualitative Concept]
   714 E C2827773:Fluctuation% [Qualitative Concept]

Phrase: "by efficient insulin-independent glucose transporters"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0596902:transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "utilization mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "(8,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.25: However, numerous studies have documented changes in higher brain functions, such as memory and mood, associated with fluctuations in the circulating glucose concentration, indicating an influence on neuronal signaling systems (4, 1618). 

Phrase: "However,"

Phrase: "numerous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "documented changes in higher brain functions,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "such as memory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: "and"

Phrase: "mood,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0026516:Mood [Mental Process]
  1000   C2713234:Mood [Clinical Attribute]
   928 E C0554980:Moody [Finding]
   900 E C0241999:MOODINESS [Mental Process]

Phrase: "associated with fluctuations"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0231239:fluctuations [Sign or Symptom]
   756 E C0231241:Fluctuation [Temporal Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   756 E C2827773:Fluctuation% [Qualitative Concept]

Phrase: "in the circulating glucose concentration,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0427743:Glucose concentration [Laboratory Procedure]
   901   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "indicating"

Phrase: "an influence on neuronal signaling systems"

Phrase: "(4,"

Phrase: "1618"

Phrase: ")."
Processing 00000000.tx.26: Here we report that in mouse brain in vivo the Akt-GSK3 signaling pathway senses physiological and pathological variations in circulating glucose levels with respondent changes in the regulatory phosphorylation states of Akt and GSK3.  

Phrase: "Here"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that in mouse brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1521713:Mouse Brain [Tissue]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "the Akt-GSK3 signaling pathway senses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0036658:senses [Organ or Tissue Function]
   717   C1515844:AKT Signaling Pathway [Molecular Function]

Phrase: "physiological"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205463:Physiological [Functional Concept]
   928 E C0031842:Physiology [Biomedical Occupation or Discipline]
   928 E C0031843:physiology [Physiologic Function]

Phrase: "and"

Phrase: "pathological variations in circulating glucose levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:variations [Qualitative Concept]

Phrase: "with respondent changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "in the regulatory phosphorylation states"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   827   C1301808:states [Geographic Area]
   793 E C1442792:State [Functional Concept]
   793 E C3148680:State [Geographic Area]

Phrase: "of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.27: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Animals and TreatmentsAdult, male C57BL/6 mice (Frederick Cancer Research, Frederick, MD), 67 weeks old, were injected intraperitoneally (ip) with streptozotocin (150 mg/kg in citrate buffer, pH 4.6) or vehicle for controls, either 3 days or 4 weeks before sacrifice. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "TreatmentsAdult,"

Phrase: "male C57BL/6 mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   912   C1521751:C57BL/6 Mouse [Mammal]
   875   C0025921:Mice, C57BL [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(Frederick Cancer Research,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1516225:Cancer Research [Research Activity]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]

Phrase: "Frederick,"

Phrase: "MD),"

Phrase: "67 weeks old,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0580836:Old [Temporal Concept]

Phrase: "were"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intraperitoneally (ip) with streptozotocin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "(150 mg/kg in citrate buffer,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0439272:mg kg [Quantitative Concept]
   783   C0126774:Mg citrate [Organic Chemical,Pharmacologic Substance]
   753   C0022718:KG [Geographic Area]
   753   C0439209:kg [Quantitative Concept]
   753   C0439269:mg% [Quantitative Concept]
   753   C1960952:mg % [Quantitative Concept]
   753   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "pH 4.6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C2678549:PH-4 [Gene or Genome]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "or"

Phrase: "vehicle for controls,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0042444:Vehicle [Biomedical or Dental Material]
   790   C0348005:Vehicle [Manufactured Object]
   718 E C0445373:Vehicular [Functional Concept]

Phrase: "either 3 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "or"

Phrase: "4 weeks before sacrifice."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C1442465:4 Weeks [Temporal Concept]
   770   C0439230:weeks [Temporal Concept]
   737 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.28: Adult male BKS.Cg-m+/+Leprdb/J mice (Jackson Laboratories), 78 weeks old, were used for a type II diabetic model animal. 

Phrase: "Adult male BKS.Cg-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   812   C3540479:CG [Gene or Genome]

Phrase: "m+/+"

Phrase: "Leprdb/J mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(Jackson Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "78 weeks old,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0580836:Old [Temporal Concept]

Phrase: "were"

Phrase: "used for a type II diabetic model animal."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0441730:Type II [Classification]
   767   C0599779:Animal Model [Animal]
   744   C0003062:Animal [Animal]
   744   C0241863:DIABETIC [Finding]
   744   C0332307:Type [Qualitative Concept]
   744   C1273517:used [Finding]
   744   C1547052:*Type [Quantitative Concept]
   744   C3161035:Model [Intellectual Product]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.29: All mice were allowed to drink ad libitum and kept on a 12 h light/dark cycle. 

Phrase: "All mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "drink"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0452428:Drink [Food]

Phrase: "ad libitum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879743:ad libitum [Qualitative Concept]

Phrase: "and"

Phrase: "kept on a 12 h light/dark cycle."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C2718082:Light-Dark Cycle [Temporal Concept]
           Light Cycle
   744   C0023693:Light [Natural Phenomenon or Process]
   744   C0033727:H+ [Element, Ion, or Isotope]
   744   C0332582:Dark [Qualitative Concept]
   744   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441932:H+ [Classification]
   744   C0564385:/h [Quantitative Concept]
   744   C1306462:Light [Functional Concept]
   744   C1511572:Cycle [Temporal Concept]
   744   C1881376:Light [Qualitative Concept]
   711   C0333118:Keep [Functional Concept]
Processing 00000000.tx.30: Where indicated, mice were given intraperitoneal injections of D-glucose (2 g/kg) or insulin (5 international units/kg bovine pancreas insulin; Sigma) in phosphate-buffered saline after overnight food withdrawal. 

Phrase: "Where"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "intraperitoneal injections of"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0021493:Injections, Intraperitoneal [Therapeutic or Preventive Procedure]
   790   C0021485:injections [Therapeutic or Preventive Procedure]
   790   C0442120:Intraperitoneal [Spatial Concept]
   790   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   790   C1828121:Injections [Functional Concept]
   756 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "D-"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(2 g/kg)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1300563:g/kg [Quantitative Concept]
   827   C0022718:KG [Geographic Area]
   827   C0439209:kg [Quantitative Concept]

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(5 international units/kg bovine pancreas insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   829   C0304866:Bovine insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "in phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "after overnight food withdrawal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2349954:Withdrawal [Activity]
   827   C2825032:Withdrawal [Mental or Behavioral Dysfunction]
Processing 00000000.tx.31: Blood glucose levels were measured using a glucose monitor (True Track Smart System). 

Phrase: "Blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a glucose monitor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0872182:glucose monitor [Medical Device]
   861   C0030695:monitor [Health Care Activity]
   861   C0150369:monitor [Health Care Activity]
   861   C0181904:Monitor [Medical Device]
   861   C0596972:Monitor [Medical Device]
   861   C1521743:Monitor [Professional or Occupational Group]
   861   C1704646:Monitor [Manufactured Object]

Phrase: "(True Track Smart System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: ")."
Processing 00000000.tx.32: Insulin concentrations were measured using an ultrasensitive mouse insulin enzyme-linked immunosorbent assay (ELISA) assay (Mercodia, Winston Salem, NC). 

Phrase: "Insulin concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an ultrasensitive mouse insulin enzyme-linked immunosorbent assay (ELISA) assay"

Phrase: "(Mercodia,"

Phrase: "Winston Salem,"

Phrase: "NC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027964:NC [Geographic Area]
  1000   C0028407:NC [Geographic Area]
  1000   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.33: Body temperatures were measured rectally using a CyQ model 111 thermocouple (CyperSense Inc, Nicholasville, KY). 

Phrase: "Body temperatures"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0005903:Temperatures, Body [Organism Attribute]
       E   temperature
   861   C0039476:Temperatures [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   777 E C1995017:Bodies [Cell Component]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "rectally"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a CyQ model 111 thermocouple"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1260870:Thermocouple [Medical Device]
   812   C1705118:Thermocouple [Medical Device]

Phrase: "(CyperSense Inc,"

Phrase: "Nicholasville,"

Phrase: "KY"

Phrase: ")."
Processing 00000000.tx.34: Tissue PreparationMice were decapitated, and brains were rapidly dissected in ice-cold saline. 

Phrase: "Tissue PreparationMice"

Phrase: "were"

Phrase: "decapitated"

Phrase: ","

Phrase: "and"

Phrase: "brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "dissected in ice-cold saline."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0456963:Ice cold [Qualitative Concept]
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0020746:Ice [Inorganic Chemical]
   760   C0036082:Saline [Substance]
   760   C0205239:dissected [Functional Concept]
   760   C0234192:Cold [Physiologic Function]
Processing 00000000.tx.35: Brain regions were homogenized in ice-cold lysis buffer containing 10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.5% Nonidet P-40, 10 g/ml leupeptin, 10 g/ml aprotinin, 5 g/ml pepstatin, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium vanadate, 50 mM sodium fluoride, and 100 nM okadaic acid. 

Phrase: "Brain regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C1273723:brain regions [Body Location or Region]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "were"

Phrase: "homogenized in ice-cold lysis buffer"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0456963:Ice cold [Qualitative Concept]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0009264:Cold [Natural Phenomenon or Process]
   753   C0009443:Cold [Disease or Syndrome]
   753   C0020746:Ice [Inorganic Chemical]
   753   C0024348:Lysis [Pathologic Function]
   753   C0234192:Cold [Physiologic Function]
   753   C1536403:lysis [Cell Function]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10 mM Tris-HCl,"

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "0.5% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   804   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   804   C0439509:/40 [Temporal Concept]

Phrase: "10 g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "10 g/ml aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "5 g/ml pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "1 mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1 mM sodium vanadate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037568:Sodium Vanadate [Inorganic Chemical,Pharmacologic Substance]
   812   C0042305:Vanadate [Inorganic Chemical]

Phrase: "50 mM sodium fluoride,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0037508:Sodium Fluoride [Biomedical or Dental Material,Inorganic Chemical]
   861   C1171560:sodium fluoride [Pharmacologic Substance]
   861   C1556062:Sodium Fluoride [Intellectual Product]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   805 E C0721463:Luride [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "100 nM okadaic acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.36: The lysates were centrifuged at 20,800 x g for 10 min to remove insoluble debris. 

Phrase: "The lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "centrifuged at 20,800 x g"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0118460:G-800 [Organic Chemical,Pharmacologic Substance]
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 10 min to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0456692:/10 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "insoluble debris."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0440266:Debris [Substance]
Processing 00000000.tx.37: Protein concentrations in the supernatants were determined in triplicate using the Bradford (19) protein assay. 

Phrase: "Protein concentrations in the supernatants"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0427716:Protein concentration [Laboratory Procedure]
   790   C1304757:Protein concentration [Laboratory or Test Result]
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "were"

Phrase: "determined in triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205174:Triplicate [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Bradford"

Phrase: "(19"

Phrase: ")"

Phrase: "protein assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.38: ImmunoblottingExtracts were mixed with Laemmli sample buffer (2% SDS) and placed in a boiling water bath for 5 min. 

Phrase: "ImmunoblottingExtracts"

Phrase: "were"

Phrase: "mixed with Laemmli sample buffer"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   797   C0258024:Laemmli buffer [Organic Chemical]
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0205430:Mixed [Functional Concept]
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]
   760   C3160715:Mixed [Finding]
   726 E C1421951:MIX [Gene or Genome]
   726 E C1720722:Mix [Qualitative Concept]

Phrase: "(2% SDS)"

Phrase: "and"

Phrase: "placed in a boiling water bath"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0439892:boiling water [Inorganic Chemical]
   783   C0179245:bath water [Medical Device]
   753   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   753   C0150141:Bath [Therapeutic or Preventive Procedure]
   753   C0599638:WATER [Substance]
   753   C1550678:Water [Inorganic Chemical]
   719   C0242301:Boil [Disease or Syndrome]
   719   C0442504:Place [Spatial Concept]
   719   C1546559:Boil [Intellectual Product]
   719   C1704765:Place [Functional Concept]
   719   C1882509:Place [Activity]
   719   C3496241:place [Disease or Syndrome]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.39: Proteins were resolved in SDS-polyacrylamide gels, and transferred to nitrocellulose. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "resolved in SDS-polyacrylamide gels,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   760   C0017243:Gels [Biomedical or Dental Material]
   760   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   760   C1514893:Resolved [Idea or Concept]
   760   C2699488:Resolved [Conceptual Entity]
   726 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   777 E C0009357:Collodion Cotton [Biomedical or Dental Material,Pharmacologic Substance]
Processing 00000000.tx.40: Blots were probed with antibodies to phospho-Ser9-GSK3, phospho-Ser21-GSK3, phospho-Tyr279/216-GSK3/, total GSK3/, phospho-Ser473-Akt, phospho-Thr308-Akt, and total Akt (Cell Signaling Technology, Beverly, MA). 

Phrase: "Blots"

Phrase: "were"

Phrase: "probed with antibodies"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "to phospho-Ser9-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phospho-Ser21-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phospho-Tyr279/216-GSK3/,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   877   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   845   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "total GSK3/,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phospho-Ser473-Akt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "phospho-Thr308-Akt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "total Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "(Cell Signaling Technology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0039421:Technology [Occupation or Discipline]
   734   C0037083:Cell Signaling [Cell Function]

Phrase: "Beverly,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.41: Immunoblots were developed using horseradish peroxidase-conjugated goat anti-mouse or goat anti-rabbit IgG (Bio-Rad), followed by detection with enhanced chemiluminescence, and statistical significance was determined using analysis of variance. 

Phrase: "Immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "were"

Phrase: "developed"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "horseradish peroxidase-conjugated goat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0018019:goat [Mammal]
   812   C1265549:goat [Mammal]
   812   C1510458:Goat [Mammal]

Phrase: "anti-mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "or"

Phrase: "goat anti-rabbit IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0034493:Rabbit [Mammal]

Phrase: "(Bio-Rad"

Phrase: ")"

Phrase: ","

Phrase: "followed by detection"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C1511790:Detection [Therapeutic or Preventive Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with enhanced chemiluminescence,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   861   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   861   C2349975:Enhanced [Activity]
   789 E C1627358:Enhancement [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "statistical significance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "analysis of variance."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]
Processing 00000000.tx.42: Enzyme ActivitiesAkt activity in the cerebral cortex was measured after immunoprecipitation of Akt from 100 g of protein with 3.5 gof monoclonal Akt antibody. 

Phrase: "Enzyme ActivitiesAkt activity in the cerebral cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0243102:enzyme activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured after immunoprecipitation of Akt"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0021069:Immunoprecipitation [Laboratory Procedure]
   760   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0444706:Measured [Qualitative Concept]
   760   C0812228:AKT [Gene or Genome]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "from 100 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with 3.5 gof monoclonal Akt antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.43: Immobilized immune complexes were washed twice with lysis buffer and twice with kinase buffer (10 mM MOPS, pH 7.4, 1 mM EDTA, 10 mM magnesium acetate, 20 mM magnesium chloride, 1 mM dithiothreitol, 1 g/ml aprotinin, 1 mM benzamidine, 50 mM -glycerophosphate, 0.1 M okadaic acid, 1 mM sodium orthovanadate, and 0.5 mM NaF). 

Phrase: "Immobilized immune complexes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0003313:Immune Complexes [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439662:Immune [Functional Concept]
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with lysis buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
   770   C1536403:lysis [Cell Function]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "twice with kinase buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "(10 mM MOPS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0066823:MOPS [Organic Chemical]
   827   C1271466:Mops [Mammal]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "10 mM magnesium acetate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0982266:magnesium acetate [Organic Chemical,Pharmacologic Substance]
   812   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: "20 mM magnesium chloride,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0024472:Magnesium Chloride [Inorganic Chemical,Pharmacologic Substance]
   812   C0008203:Chloride, NOS [Inorganic Chemical]
   812   C0024467:Magnesium [Element, Ion, or Isotope]
   812   C0596019:Chloride [Element, Ion, or Isotope]
   812   C2348270:MAGNESIUM [Element, Ion, or Isotope]

Phrase: "1 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "1 g/ml aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "1 mM benzamidine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0053140:benzamidine [Organic Chemical,Pharmacologic Substance]

Phrase: "50 mM -glycerophosphate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017881:glycerophosphate [Carbohydrate,Lipid]

Phrase: "0.1 M okadaic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]

Phrase: "1 mM sodium orthovanadate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0029366:Orthovanadate [Inorganic Chemical]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.5 mM NaF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   812   C1366571:NAF [Gene or Genome]
   812   C1705592:NAF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.44: Kinase activity was measured by mixing immunoprecipitates with 30 l of kinase buffer containing 125 M ATP, 1.4 Ci of [-32P]ATP (Amersham Biosciences), and 100 M crosstide peptide substrate (Upstate%20Biotechnology">Upstate Biotechnology, Inc., Lake Placid, NY). 

Phrase: "Kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150423:kinase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured by mixing immunoprecipitates"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0205430:mixing [Functional Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737   C0301871:Immunoprecipitate [Immunologic Factor]
   737 E C1421951:MIX [Gene or Genome]
   737 E C1720722:Mix [Qualitative Concept]

Phrase: "with 30 l"

Phrase: "of kinase buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "125 M ATP,"

Phrase: "1.4 Ci of [-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1553631:32p [Medical Device]

Phrase: "]ATP"

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "100 M crosstide peptide substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1710236:Substrate [Manufactured Object]

Phrase: "(Upstate%20Biotechnology"""

Phrase: ">Upstate Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Inc.,"

Phrase: "Lake Placid, NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027976:NY [Geographic Area]
   827   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.45: The samples were incubated at 30 C for 20 min, centrifuged, and triplicates were spotted onto P81 filter paper. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "incubated at 30 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 20 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "centrifuged,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "and"

Phrase: "triplicates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205174:Triplicate [Quantitative Concept]

Phrase: "were"

Phrase: "spotted onto P81 filter paper."
Meta Candidates (Total=18; Excluded=5; Pruned=0; Remaining=13)
   806   C0180859:filter paper [Medical Device]
   760   C0030351:Paper [Manufactured Object]
   760   C0059973:p81 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0180860:Filter [Manufactured Object]
   760   C0581406:Filter [Medical Device]
   760   C1522664:Filter [Intellectual Product]
   760   C1547566:Paper [Idea or Concept]
   760   C1704449:Filter [Conceptual Entity]
   760   C1704684:Filter [Medical Device]
   760   C1875155:FILTER [Medical Device]
   726   C0329155:Spot [Fish]
   726   C1427618:SPOT [Gene or Genome]
   726   C1705203:Spot [Conceptual Entity]
   704 E C0080194:Strain [Injury or Poisoning]
   704 E C0442694:Straining [Physiologic Function]
   704 E C0456178:strain [Intellectual Product]
   704 E C1518614:Strain [Organism]
   704 E C2987481:Strain [Mental Process]
Processing 00000000.tx.46: The filter papers were washed four times in 0.5% phosphoric acid for a total time of 1 h, rinsed in 95% ethanol, air-dried for 30 min, and counted in a liquid scintillation counter. 

Phrase: "The filter papers"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
  1000   C0180859:filter papers [Medical Device]
   861   C0030351:Papers [Manufactured Object]
   861   C0180860:Filter [Manufactured Object]
   861   C0581406:Filter [Medical Device]
   861   C1522664:Filter [Intellectual Product]
   861   C1704449:Filter [Conceptual Entity]
   861   C1704684:Filter [Medical Device]
   861   C1875155:FILTER [Medical Device]
   827 E C1547566:Paper [Idea or Concept]
   805 E C0080194:Strain [Injury or Poisoning]
   805 E C0442694:Straining [Physiologic Function]
   805 E C0456178:strain [Intellectual Product]
   805 E C1518614:Strain [Organism]
   805 E C2987481:Strain [Mental Process]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "four times in 0.5% phosphoric acid"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]

Phrase: "for a total time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "of 1 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "rinsed in 95% ethanol,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001962:Ethanol [Organic Chemical]
   737   C1701810:Rinse [Functional Concept]
   737   C1882955:Rinse [Activity]

Phrase: "air-dried for 30 min,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0456693:/30 min [Temporal Concept]
   806   C1442458:30 min [Temporal Concept]
   760   C0001861:Air [Substance]
   760   C0702093:/min [Temporal Concept]
   760   C1512080:Dried [Qualitative Concept]
   760   C2827485:Dried [Body Substance]
   760   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   726 E C0011682:Dry [Natural Phenomenon or Process]
   726 E C0205222:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "counted in a liquid scintillation counter."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0036405:Scintillation Counter [Medical Device]
   790   C1710025:Scintillation Counter [Manufactured Object]
   753   C0302908:Liquid [Substance]
   753   C0677601:Counter [Manufactured Object]
   753   C0678573:scintillation [Natural Phenomenon or Process]
   753   C1304698:Liquid [Finding]
   753   C1546699:Liquid NOS [Intellectual Product]
   753   C1561501:Liquid NOS [Substance]
   753   C1705206:Counter [Medical Device]
   719   C0750480:Count [Activity]
   719   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.47: Akt activity in epididymal fat was measured after immunoprecipitation from 200 g of protein using a nonradioactive Akt activity assay kit (Cell Signaling Technology). 

Phrase: "Akt activity in epididymal fat"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured after immunoprecipitation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "from 200 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a nonradioactive Akt activity assay kit (Cell Signaling Technology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0039421:Technology [Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.48: GSK3 activity in cerebral cortex and epididymal fat was measured after immunoprecipitation of GSK3 from 100 g of protein with 3 g of polyclonal GSK3 antibody. 

Phrase: "GSK3 activity in cerebral cortex"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   869   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   822   C2261482:glycogen synthase kinase activity [Molecular Function]
   793   C1152133:glycogen synthase activity [Molecular Function]
   767   C1150423:kinase activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "epididymal fat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0424612:FAT [Organism Attribute]

Phrase: "was"

Phrase: "measured after immunoprecipitation of GSK3"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   833   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   744   C0021069:Immunoprecipitation [Laboratory Procedure]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0444706:Measured [Qualitative Concept]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]

Phrase: "from 100 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with 3 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "of polyclonal GSK3 antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.49: Immobilized immune complexes were washed twice with lysis buffer and twice with kinase buffer. 

Phrase: "Immobilized immune complexes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0003313:Immune Complexes [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439662:Immune [Functional Concept]
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with lysis buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
   770   C1536403:lysis [Cell Function]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "twice with kinase buffer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]
Processing 00000000.tx.50: Kinase activity was measured by mixing immunoprecipitates with 30 l of kinase buffer containing 125 M ATP, 1.4 Ci of [-32P]ATP, and 100 M phosphoglycogen synthase peptide-2 substrate (Upstate%20Biotechnology">Upstate Biotechnology, Inc.). 

Phrase: "Kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150423:kinase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured by mixing immunoprecipitates"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0205430:mixing [Functional Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737   C0301871:Immunoprecipitate [Immunologic Factor]
   737 E C1421951:MIX [Gene or Genome]
   737 E C1720722:Mix [Qualitative Concept]

Phrase: "with 30 l"

Phrase: "of kinase buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "125 M ATP,"

Phrase: "1.4 Ci of [-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1553631:32p [Medical Device]

Phrase: "]ATP,"

Phrase: "and"

Phrase: "100 M phosphoglycogen synthase peptide-2 substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1710236:Substrate [Manufactured Object]

Phrase: "(Upstate%20Biotechnology"""

Phrase: ">Upstate Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.51: The samples were incubated at 30 C for 20 min, centrifuged, triplicates were spotted onto P81 filter paper, and treated as in the Akt activity assay. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "incubated at 30 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 20 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "centrifuged,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "triplicates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205174:Triplicate [Quantitative Concept]

Phrase: "were"

Phrase: "spotted onto P81 filter paper,"
Meta Candidates (Total=18; Excluded=5; Pruned=0; Remaining=13)
   806   C0180859:filter paper [Medical Device]
   760   C0030351:Paper [Manufactured Object]
   760   C0059973:p81 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0180860:Filter [Manufactured Object]
   760   C0581406:Filter [Medical Device]
   760   C1522664:Filter [Intellectual Product]
   760   C1547566:Paper [Idea or Concept]
   760   C1704449:Filter [Conceptual Entity]
   760   C1704684:Filter [Medical Device]
   760   C1875155:FILTER [Medical Device]
   726   C0329155:Spot [Fish]
   726   C1427618:SPOT [Gene or Genome]
   726   C1705203:Spot [Conceptual Entity]
   704 E C0080194:Strain [Injury or Poisoning]
   704 E C0442694:Straining [Physiologic Function]
   704 E C0456178:strain [Intellectual Product]
   704 E C1518614:Strain [Organism]
   704 E C2987481:Strain [Mental Process]

Phrase: "and"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "as in the Akt activity assay."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205177:Activity [Functional Concept]
   753   C0243073:assay [Qualitative Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0812228:AKT [Gene or Genome]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.52: GSK3 activity in cerebral cortex and epididymal fat was measured as described previously (20) after immunoprecipitation of GSK3 from 100 g or 200 g of protein, respectively, with 1.5 g of monoclonal GSK3 antibody. 

Phrase: "GSK3 activity in cerebral cortex"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   869   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   822   C2261482:glycogen synthase kinase activity [Molecular Function]
   793   C1152133:glycogen synthase activity [Molecular Function]
   767   C1150423:kinase activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "epididymal fat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0424612:FAT [Organism Attribute]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(20"

Phrase: ")"

Phrase: "after"

Phrase: "immunoprecipitation of GSK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021069:Immunoprecipitation [Laboratory Procedure]
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "from 100 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "or"

Phrase: "200 g of protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0060916:protein g [Amino Acid, Peptide, or Protein]
   819   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0439267:g% [Quantitative Concept]

Phrase: "respectively,"

Phrase: "with 1.5 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439267:g% [Quantitative Concept]
   734   C0450316:1/5 [Quantitative Concept]

Phrase: "of monoclonal GSK3 antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.53: Immobilized immune complexes were washed as for GSK3. 

Phrase: "Immobilized immune complexes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0003313:Immune Complexes [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439662:Immune [Functional Concept]
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "washed as for GSK3."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1548982:Washed [Idea or Concept]
   714 E C0441648:Wash [Activity]
Processing 00000000.tx.54: Kinase activity was measured by mixing immunoprecipitates with 30 l of kinase buffer containing 125 M ATP, 1.4 Ci of [-32P]ATP, and 0.1 g/l recombinant Tau protein (Panvera, Madison, WI). 

Phrase: "Kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150423:kinase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured by mixing immunoprecipitates"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0205430:mixing [Functional Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737   C0301871:Immunoprecipitate [Immunologic Factor]
   737 E C1421951:MIX [Gene or Genome]
   737 E C1720722:Mix [Qualitative Concept]

Phrase: "with 30 l"

Phrase: "of kinase buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "125 M ATP,"

Phrase: "1.4 Ci of [-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1553631:32p [Medical Device]

Phrase: "]ATP,"

Phrase: "and"

Phrase: "0.1 g/l recombinant Tau protein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   829   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   818   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1720655:Tau [Intellectual Product]
   795   C1947974:Tau [Research Activity]

Phrase: "(Panvera,"

Phrase: "Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")."
Processing 00000000.tx.55: The samples were incubated at 30 C for 15 min, and 25 l of Laemmli sample buffer (2% SDS) was added to each sample to stop the reaction. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "incubated at 30 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 15 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "25 l of Laemmli sample buffer"

Phrase: "(2% SDS)"

Phrase: "was"

Phrase: "added to each"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1947925:Stop [Activity]
  1000   C2746065:Stop [Temporal Concept]

Phrase: "the reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.56: Samples were placed in a boiling water bath for 5 min, and proteins were separated in 7.5% SDS-polyacrylamide gels. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "placed in a boiling water bath"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0439892:boiling water [Inorganic Chemical]
   783   C0179245:bath water [Medical Device]
   753   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   753   C0150141:Bath [Therapeutic or Preventive Procedure]
   753   C0599638:WATER [Substance]
   753   C1550678:Water [Inorganic Chemical]
   719   C0242301:Boil [Disease or Syndrome]
   719   C0442504:Place [Spatial Concept]
   719   C1546559:Boil [Intellectual Product]
   719   C1704765:Place [Functional Concept]
   719   C1882509:Place [Activity]
   719   C3496241:place [Disease or Syndrome]

Phrase: "for 5 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "separated in 7.5% SDS-polyacrylamide gels."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   714 E C1382104:Gel [Substance]
Processing 00000000.tx.57: The gels were vacuum-dried, exposed to a phosphorscreen overnight, and quantitated using a PhosphorImager (Molecular Dynamics, Sunnyvale, CA). 

Phrase: "The gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "vacuum-dried,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1512080:Dried [Qualitative Concept]
   861   C2827485:Dried [Body Substance]

Phrase: "exposed to a phosphorscreen overnight,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "quantitated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a PhosphorImager"

Phrase: "(Molecular Dynamics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: "Sunnyvale,"

Phrase: "CA)."
Processing 00000000.tx.58: The efficiencies of immunoprecipitations were determined by immunoblotting with appropriate antibodies. 

Phrase: "The efficiencies of immunoprecipitations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0013682:efficiencies [Quantitative Concept]

Phrase: "were"

Phrase: "determined by immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "with appropriate antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.59: View larger version (77K): [in this window] [in a new window]  FIGURE 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(77K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 1."
Processing 00000000.tx.60: Food withdrawal for 24 h decreased the phosphorylation of Akt and GSK3 in mouse brain. 

Phrase: "Food withdrawal for 24 h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C2349954:Withdrawal [Activity]
   760   C2825032:Withdrawal [Mental or Behavioral Dysfunction]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "GSK3 in mouse brain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.61: Food was withheld for 24 h and then protein extracts from the cerebral cortex and hippocampus (n = 4 per group) were immunoblotted for Phospho-Thr308-Akt, Phospho-Ser473-Akt, and Total Akt (A) and Phospho-Ser21-GSK3, Phospho-Ser9-GSK3, Phospho-Tyr279/216-GSK3/, and Total GSK3/ (B).   

Phrase: "Food"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "was"

Phrase: "withheld for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "then protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extracts from the cerebral cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]
   760   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(n = 4 per group"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   819   C0441848:Group N [Intellectual Product]
   819   C0441876:Group 4 [Intellectual Product]
   770   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441833:Group [Idea or Concept]
   770   C0441922:N+ [Intellectual Product]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1553036:[n] [Quantitative Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: ")"

Phrase: "were"

Phrase: "immunoblotted for Phospho-Thr308-Akt,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0812228:AKT [Gene or Genome]
   726   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "Phospho-Ser473-Akt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "Total Akt (A)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "Phospho-Ser21-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Phospho-Ser9-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Phospho-Tyr279/216-GSK3/,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   877   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   845   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Total GSK3/"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.62: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Brain Akt and GSK3 Are Dephosphorylated during FastingTo test if the Akt-GSK3 coupled signaling pathway in mammalian brain is sensitive to peripheral glucose availability, we first examined if food withdrawal for 24 h affected the phosphorylation levels of Akt and GSK3 in mouse brain. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Brain Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Are"

Phrase: "Dephosphorylated during FastingTo"

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "if"

Phrase: "the Akt-GSK3 coupled signaling pathway in mammalian brain"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   767   C1515844:AKT Signaling Pathway [Molecular Function]
   753   C0037083:signaling pathway [Cell Function]
   753   C0086982:Signaling Pathway [Molecular Function]
   751 E C0037080:pathway signaling [Molecular Function]
   751   C0815011:brain pathway [Body Part, Organ, or Organ Component]
   736   C1704259:Pathway [Molecular Function]
   736   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "sensitive to peripheral glucose availability,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]

Phrase: "we first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "if"

Phrase: "food withdrawal for 24 h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C2349954:Withdrawal [Activity]
   760   C2825032:Withdrawal [Mental or Behavioral Dysfunction]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the phosphorylation levels of Akt"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "GSK3 in mouse brain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.63: These measurements used immunoblot analyses with phosphospecific antibodies to Akt or each of the two isoforms of GSK3 in samples of cerebral cortex and hippocampus obtained from adult, male C57BL/6 mice, with four mice per group. 

Phrase: "These measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunoblot analyses with phosphospecific antibodies"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]

Phrase: "to Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "or"

Phrase: "each of the two isoforms of GSK3"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205448:Two [Quantitative Concept]
   739   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   739   C1457900:Each [Quantitative Concept]

Phrase: "in samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "of cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "obtained from adult,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0001675:Adult [Age Group]
   790   C1301820:Obtained [Functional Concept]
   790   C1706450:Adult [Human]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "male C57BL/6 mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   912   C1521751:C57BL/6 Mouse [Mammal]
   875   C0025921:Mice, C57BL [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "with four mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "per group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.64: Food withdrawal significantly reduced blood glucose concentrations to 66  4% of control levels, reduced blood insulin levels to 51  3% of controls, but did not significantly change body weight or temperature (TABLE ONE). 

Phrase: "Food withdrawal significantly reduced blood glucose concentrations to 66  4%"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   765   C2585282:Blood glucose concentration [Finding]
   757   C0427728:blood concentrations [Laboratory or Test Result]
   757   C0427743:concentrations glucose [Laboratory Procedure]
   757   C0699870:blood concentrations [Quantitative Concept]
   757   C1287281:concentrations glucose [Laboratory or Test Result]
   757   C1313904:blood concentrations [Laboratory Procedure]
   741   C0424099:Reduced concentration [Finding]
   739   C0086045:Concentrations [Mental Process]
   706 E C1446561:Concentration [Quantitative Concept]

Phrase: "of control levels,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0243148:control [Qualitative Concept]
   861   C0441889:Levels [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "reduced blood insulin levels to 51  3% of controls,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   764   C0202098:insulin levels [Laboratory Procedure]
   764   C0428405:insulin levels [Laboratory or Test Result]
   764   C0853230:blood insulin [Laboratory Procedure]
   745   C0456949:Level 3 [Intellectual Product]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0441889:Levels [Qualitative Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "but"

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "body weight"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0005910:Body Weight [Organism Attribute]
           weight
  1000   C1305866:body weight [Diagnostic Procedure]
           weight
   861   C0043100:Weight [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "or"

Phrase: "temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005903:temperature [Organism Attribute]
  1000   C0039476:*Temperature [Quantitative Concept]

Phrase: "(TABLE ONE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.65: It has been reported that hypothermia during hypoglycemia caused by three days of starvation increased phospho-Ser9-GSK3 levels in mouse brain (21); 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that hypothermia during hypoglycemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020672:Hypothermia [Finding]
   770   C0413252:hypothermia [Injury or Poisoning]

Phrase: "caused by three days of starvation"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0038187:Starvation [Finding]
   753   C0205449:Three [Quantitative Concept]
   753   C0439228:days [Temporal Concept]
   719   C0015127:cause [Functional Concept]
   719 E C0332173:/day [Temporal Concept]
   719 E C0439505:/day [Temporal Concept]
   719   C1524003:Cause [Conceptual Entity]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "phospho-Ser9-GSK3 levels in mouse brain"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   741   C0456949:Level 3 [Intellectual Product]
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "(21"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.66: thus, in the present study, temperature was monitored to ensure that hypothermia did not occur to obscure the effects of changes in glucose. 

Phrase: "thus,"

Phrase: "in the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005903:temperature [Organism Attribute]
  1000   C0039476:*Temperature [Quantitative Concept]

Phrase: "was"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that hypothermia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020672:Hypothermia [Finding]
  1000   C0413252:hypothermia [Injury or Poisoning]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obscure"

Phrase: "the effects of changes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "in glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.67: In both brain regions food withdrawal resulted in large decreases of the dual phosphorylation of Akt, phospho-Thr308-Akt (in the cortex to 24  6% of control, means  S.E.; n = 4) and phospho-Ser473-Akt (in the cortex to 41  8% of control), but the total level of Akt was unaffected (Fig. 1A). 

Phrase: "In both brain regions food withdrawal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2349954:Withdrawal [Activity]
   812   C2825032:Withdrawal [Mental or Behavioral Dysfunction]

Phrase: "resulted in large decreases of the dual phosphorylation of Akt,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   739   C0031715:Phosphorylation [Molecular Function]
   739   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0547047:decreases [Quantitative Concept]
   739   C0549177:Large [Quantitative Concept]
   739   C0812228:AKT [Gene or Genome]
   739   C1158886:Phosphorylation [Molecular Function]
   739   C1554184:Dual [Intellectual Product]
   706 E C0392756:Decrease [Qualitative Concept]
   706   C1274040:Result [Functional Concept]
   706   C1546471:Result [Idea or Concept]
   706   C2825142:Result [Finding]

Phrase: "phospho-Thr308-Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "("

Phrase: "in the cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "to 24  6%"

Phrase: "of control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "; n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "phospho-Ser473-Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "("

Phrase: "in the cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "to 41  8%"

Phrase: "of control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "the total level of Akt"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "unaffected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986417:Unaffected [Conceptual Entity]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.68: There were also large decreases in the serine phosphorylation of both isoforms of GSK3, phospho-Ser9-GSK3 (in the cortex to 38  9% of control) and phospho-Ser21-GSK3 (in the cortex to 30  5% of control), whereas phosphotyrosine and total levels of GSK3 and GSK3 were unaltered (Fig. 1B). 

Phrase: "There"

Phrase: "were"

Phrase: "also large decreases in the serine phosphorylation of both isoforms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0547047:decreases [Quantitative Concept]
   706 E C0392756:Decrease [Qualitative Concept]

Phrase: "of GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phospho-Ser9-GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "in the cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "to 38  9%"

Phrase: "of control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "phospho-Ser21-GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "in the cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "to 30  5%"

Phrase: "of control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "phosphotyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "total levels of GSK3"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456949:Level 3 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "unaltered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709843:Unaltered [Qualitative Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.69: Thus, decreased blood glucose and insulin concentrations caused by food withdrawal for 24 h were associated with decreases in the phosphorylation of Akt and GSK3 in two regions of mouse brain. 

Phrase: "Thus,"

Phrase: "decreased blood glucose"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   913   C0860801:decreased glucose [Finding]
   901   C0005802:Blood Glucose [Carbohydrate]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "insulin concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "caused by food withdrawal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0016452:Food [Food]
   770   C2349954:Withdrawal [Activity]
   770   C2825032:Withdrawal [Mental or Behavioral Dysfunction]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "were"

Phrase: "associated with decreases"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0547047:decreases [Quantitative Concept]
   756 E C0392756:Decrease [Qualitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3 in two regions of mouse brain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.70: View this table: [in this window] [in a new window]  TABLE ONE Body weight, blood glucose, serum insulin, and body temperature of control and 24 h fasted mice  View larger version (28K): [in this window] [in a new window]  FIGURE 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE ONE Body weight,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   861   C0005910:Body Weight [Organism Attribute]
           weight
   861   C1305866:body weight [Diagnostic Procedure]
           weight
   812   C0043100:Weight [Quantitative Concept]
   812   C0242821:body [Human]
   812   C0460148:Body [Anatomical Structure]
   812   C1268086:Body [Anatomical Structure]
   812   C1705104:Weight [Idea or Concept]
   729 E C1995017:Bodies [Cell Component]

Phrase: "blood glucose,"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "serum insulin,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0428357:Serum insulin [Laboratory Procedure]
  1000   C1261415:serum insulin [Laboratory or Test Result]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "body temperature of control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0005903:Body Temperature [Organism Attribute]
           temperature
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0242821:body [Human]
   770   C0460148:Body [Anatomical Structure]
   770   C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "24 h fasted mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 2."
Processing 00000000.tx.71: Glucose administration increased the phosphorylation of Akt and GSK3 in mouse brain. 

Phrase: "Glucose administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001554:Administration [Occupational Activity]
   861   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "GSK3 in mouse brain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.72: Food was withdrawn overnight (14 h) and after an ip injection of 2 g/kg glucose, blood glucose and serum insulin concentrations were measured (A), and protein extracts from the cerebral cortex and hippocampus were immunoblotted for Phospho-Thr308-Akt, Phospho-Ser473-Akt, and Total Akt (B), and Phospho-Ser21-GSK3, Phos-pho-Ser9-GSK3, Phospho-Tyr279/216-GSK3/, and Total GSK3/ (C). 

Phrase: "Food"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "was"

Phrase: "withdrawn"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0424092:Withdrawn [Finding]
  1000   C2349954:Withdrawn [Activity]
  1000   C2825032:Withdrawn [Mental or Behavioral Dysfunction]

Phrase: "overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "(14 h)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and after an ip injection of 2 g/kg glucose,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C1300563:g/kg [Quantitative Concept]
   739   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   739   C0021485:injection [Therapeutic or Preventive Procedure]
   739   C0022718:KG [Geographic Area]
   739   C0439209:kg [Quantitative Concept]
   739   C0439267:g% [Quantitative Concept]
   739   C1272883:Injection [Biomedical or Dental Material]
   739   C1515981:And [Idea or Concept]
   739   C1533685:Injection [Therapeutic or Preventive Procedure]
   739   C1828121:Injection [Functional Concept]

Phrase: "blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "serum insulin concentrations"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   896   C0683149:serum concentration [Quantitative Concept]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0428357:Serum insulin [Laboratory Procedure]
   734   C1261415:serum insulin [Laboratory or Test Result]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extracts from the cerebral cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]
   760   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "immunoblotted for Phospho-Thr308-Akt,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0812228:AKT [Gene or Genome]
   726   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "Phospho-Ser473-Akt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "Total Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Phospho-Ser21-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Phos-pho-Ser9-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   877   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   845   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Phospho-Tyr279/216-GSK3/,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   877   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   845   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Total GSK3/"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.73: Quantitative values were obtained by densitometric measurements of immunoblots and are means  S.E. from three mice per group.  

Phrase: "Quantitative values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "obtained by densitometric measurements of immunoblots"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0242485:measurements [Functional Concept]
   753   C1301820:Obtained [Functional Concept]
   719   C0020985:Immunoblot [Laboratory Procedure]
   719 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "are"

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from three mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "per group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.74: Brain Akt and GSK3 Are Phosphorylated after Glucose Administration Because food withdrawal indicated there was an inverse relationship between blood glucose and/or insulin levels and the phosphorylation of brain Akt and GSK3, the converse experiment was carried out in which a bolus of glucose was administered to mice. 

Phrase: "Brain Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Are"

Phrase: "Phosphorylated after Glucose Administration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001554:Administration [Occupational Activity]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "Because"

Phrase: "food withdrawal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2349954:Withdrawal [Activity]
   861   C2825032:Withdrawal [Mental or Behavioral Dysfunction]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "there"

Phrase: "was"

Phrase: "an inverse relationship between blood glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439849:Relationship [Qualitative Concept]
   753   C1705630:Relationship [Idea or Concept]
   753   C1706279:Relationship [Idea or Concept]
   753   C3540605:Relationship [Intellectual Product]

Phrase: "and/or"

Phrase: "insulin levels"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0202098:insulin levels [Laboratory Procedure]
  1000   C0428405:insulin levels [Laboratory or Test Result]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the phosphorylation of brain Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the converse experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]

Phrase: "a bolus of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511237:Bolus [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "administered to mice."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C1521801:Administered [Functional Concept]
   756 E C1621583:Administer [Functional Concept]
Processing 00000000.tx.75: To provide a consistent baseline blood glucose level in all of the mice, the glucose was administered after a 14-h period of food withdrawal. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a consistent baseline blood glucose level in all of the mice,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   775   C0428554:Blood glucose level [Laboratory or Test Result]
   756   C0005802:Blood Glucose [Carbohydrate]
   756   C0337438:glucose level [Laboratory Procedure]
   756   C0428548:Glucose level [Laboratory or Test Result]
   738   C0005767:Blood [Tissue]
   738   C0005768:blood [Body Substance]
   738   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   738   C0229664:Blood [Body Substance]
   738   C0441889:Level [Qualitative Concept]
   738   C0456079:Level [Classification]
   738   C1547707:Level [Geographic Area]
   738   C2946261:Level [Pharmacologic Substance]
   737   C1511225:Mouse Blood [Tissue]

Phrase: "the glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "administered after a 14-h period of food withdrawal."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   742   C0016452:Food [Food]
   742   C0033727:H+ [Element, Ion, or Isotope]
   742   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0439531:/period [Temporal Concept]
   742   C0441932:H+ [Classification]
   742   C0564385:/h [Quantitative Concept]
   742   C1521801:Administered [Functional Concept]
   742   C1948053:Period [Temporal Concept]
   742   C2349954:Withdrawal [Activity]
   742   C2825032:Withdrawal [Mental or Behavioral Dysfunction]
   708 E C1621583:Administer [Functional Concept]
Processing 00000000.tx.76: Following treatment with 2 g/kg glucose, the blood glucose and insulin levels rapidly increased and reached peak levels after 10 and 5 min, respectively, (Fig. 2A) whereas body temperature was not changed. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "treatment with 2 g/kg glucose,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "the blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "insulin levels rapidly"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "reached peak levels after 10"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0444505:Peak level [Quantitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "5 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "respectively,"

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: "whereas"

Phrase: "body temperature"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0005903:Body Temperature [Organism Attribute]
           temperature
   861   C0039476:*Temperature [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   777 E C1995017:Bodies [Cell Component]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "changed."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.77: Glucose administration caused rapid and substantial increases in the levels of phospho-Thr308-Akt, phospho-Ser473-Akt, phospho-Ser21-GSK3, and phospho-Ser9-GSK3 in both the cerebral cortex and the hippocampus (Fig. 2, B and C). 

Phrase: "Glucose administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001554:Administration [Occupational Activity]
   861   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "substantial increases in the levels of phospho-Thr308-Akt,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:increases [Functional Concept]

Phrase: "phospho-Ser473-Akt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "phospho-Ser21-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "phospho-Ser9-GSK3 in both"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.78: Taken together, the results of food deprivation and of glucose administration show that the phosphorylation states of Akt and GSK3 in two regions of mouse brain are regulated by both decreases and increases in the circulating levels of glucose and insulin. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the results of food deprivation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "and of glucose administration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0001554:Administration [Occupational Activity]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C1515981:And [Idea or Concept]
   770   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the phosphorylation states of Akt"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C1301808:states [Geographic Area]
   726 E C1442792:State [Functional Concept]
   726 E C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "GSK3 in two regions of mouse brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "regulated by both decreases"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0547047:decreases [Quantitative Concept]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   737 E C0392756:Decrease [Qualitative Concept]

Phrase: "and"

Phrase: "increases in the circulating levels of glucose"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   774   C0428548:glucose levels [Laboratory or Test Result]
   761   C0017747:Glucose, increased level [Finding]
   757 E C0337438:glucose level [Laboratory Procedure]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0175630:Circulating [Functional Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C0442805:Increase [Functional Concept]
   732   C0860803:glucose increased [Finding]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.79: Brain Akt and GSK3 Are Transiently Phosphorylated after Insulin AdministrationTo test if increased insulin was sufficient to trigger changes in brain Akt and GSK3 phosphorylation, insulin was administered to mice. 

Phrase: "Brain Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Are"

Phrase: "Transiently"

Phrase: "Phosphorylated after Insulin AdministrationTo"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "if"

Phrase: "increased insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0020459:increased insulin [Disease or Syndrome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "changes in brain Akt"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "GSK3 phosphorylation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "administered to mice."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C1521801:Administered [Functional Concept]
   756 E C1621583:Administer [Functional Concept]
Processing 00000000.tx.80: Administration of 5 international units/kg insulin caused a large increase in blood insulin and a subsequent decrease in blood glucose (Fig. 3A). 

Phrase: "Administration of 5 international units/kg insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0199782:Administration of insulin [Therapeutic or Preventive Procedure]
           administration insulin
   748   C0001554:Administration [Occupational Activity]
   748   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a large increase in blood insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0020459:INSULIN INCREASE [Disease or Syndrome]
   753   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "a subsequent decrease in blood glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.81: The rapid increase in insulin concentration caused a rapid but transient increase in the dual phosphorylation of Akt in cerebral cortex and hippocampus (Fig. 3B). 

Phrase: "The rapid increase in insulin concentration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0020459:INSULIN INCREASE [Disease or Syndrome]
   753   C0442805:Increase [Functional Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "but"

Phrase: "transient increase in the dual phosphorylation of Akt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "in cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.82: Akt phosphorylation reached a peak 5 min after insulin administration, which rapidly reverted to basal levels as the glucose concentration plummeted, although the insulin concentration remained elevated. 

Phrase: "Akt phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "a peak 5 min after insulin administration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0702093:/min [Temporal Concept]

Phrase: "which rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "reverted to basal levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0205112:Basal [Spatial Concept]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "as the glucose concentration plummeted,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0427743:Glucose concentration [Laboratory Procedure]
   734   C1287281:Glucose concentration [Laboratory or Test Result]

Phrase: "although"

Phrase: "the insulin concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "remained"

Phrase: "elevated."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]
Processing 00000000.tx.83: Similar patterns of changes in the phosphorylation of both GSK3 isoforms occurred in both brain regions (Fig. 3C). 

Phrase: "Similar patterns of changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1272746:changes patterns [Qualitative Concept]
   770   C0449774:Patterns [Spatial Concept]

Phrase: "in the phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "of both GSK3 isoforms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "occurred in both brain regions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1273723:brain regions [Body Location or Region]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1709305:Occurred [Activity]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.84: These results suggest that both glucose and insulin contribute to regulating the phosphorylation states of Akt and GSK3 in the brain in vivo. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "both glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulating"

Phrase: "the phosphorylation states of Akt"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C1301808:states [Geographic Area]
   726 E C1442792:State [Functional Concept]
   726 E C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "GSK3 in the brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.85: Overall, these experiments demonstrate that the regulatory phosphorylation states of Akt and GSK3 in mouse cerebral cortex and hippocampus are modulated in an inverse manner by fluctuations in the blood glucose concentration, such that the kinases are dephosphorylated when blood glucose levels are below normal, and are phosphorylated when blood glucose levels are elevated, and that circulating insulin is also able to modulate Akt and GSK3 in the brain. 

Phrase: "Overall,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "these experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the regulatory phosphorylation states of Akt"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1301808:states [Geographic Area]
   719 E C1442792:State [Functional Concept]
   719 E C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "GSK3 in mouse cerebral cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "modulated in an inverse manner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439850:Inverse [Qualitative Concept]
   760   C0443264:Modulated [Spatial Concept]

Phrase: "by fluctuations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0231239:fluctuations [Sign or Symptom]
   966 E C0231241:Fluctuation [Temporal Concept]
   966 E C2827773:Fluctuation% [Qualitative Concept]

Phrase: "in the blood glucose concentration,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C2585282:Blood glucose concentration [Finding]
   913   C0427728:Blood concentration [Laboratory or Test Result]
   913   C0699870:blood concentration [Quantitative Concept]
   913   C1313904:Blood concentration [Laboratory Procedure]
   901   C0427743:Glucose concentration [Laboratory Procedure]
   901   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0005802:Blood Glucose [Carbohydrate]

Phrase: "such"

Phrase: "that"

Phrase: "the kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "dephosphorylated"

Phrase: "when"

Phrase: "blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "are below normal,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205307:Normal [Qualitative Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C1551058:Are [Quantitative Concept]
   790   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "phosphorylated"

Phrase: "when"

Phrase: "blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "are"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "that circulating insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "also able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3 in the brain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.86: This raised the question of whether changes in circulating glucose in the absence of insulin is sufficient to regulate these kinases in the brain, which can occur in pathological states of hyperglycemia associated with diabetes. 

Phrase: "This raised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442818:Raised [Quantitative Concept]

Phrase: "the question of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1522634:Question [Intellectual Product]

Phrase: "whether"

Phrase: "changes in circulating glucose"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "regulate"

Phrase: "these kinases in the brain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which"

Phrase: "can"

Phrase: "occur in pathological states of hyperglycemia"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0020456:Hyperglycaemia [Disease or Syndrome]
   753   C0030664:Pathological [Biomedical Occupation or Discipline]
   753   C1301808:states [Geographic Area]
   753   C1521733:Pathological [Functional Concept]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]
   719 E C1442792:State [Functional Concept]
   719 E C3148680:State [Geographic Area]

Phrase: "associated with diabetes."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.87: Diabetes Increases Brain Akt and GSK3 PhosphorylationHyperglycemic conditions in mouse models of diabetes were used to test if short and long term pathological increases in circulating glucose levels regulate the phosphorylation of brain Akt and GSK3. 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "Increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "Brain Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3 PhosphorylationHyperglycemic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "conditions in mouse"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   790   C0012634:condition [Disease or Syndrome]
   790   C0025914:Mouse [Mammal]
   790   C0025929:mouse [Mammal]
   790   C0026809:Mouse [Mammal]
   790   C0348080:Condition [Qualitative Concept]
   790   C1705253:Condition [Conceptual Entity]
   734 E C0040607:Training [Educational Activity]
   734 E C0220931:Training [Educational Activity]
   734 E C0336809:Train [Manufactured Object]
   734 E C1552514:Train [Manufactured Object]
   734 E C2673163:training [Qualitative Concept]
   706 E C0009647:Conditioned [Mental Process]

Phrase: "models of diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C3161035:Model [Intellectual Product]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "if"

Phrase: "short"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1282927:short [Qualitative Concept]
  1000   C1806781:Short [Quantitative Concept]
  1000   C2350002:Short [Quantitative Concept]

Phrase: "and"

Phrase: "long term pathological increases in circulating glucose levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:increases [Functional Concept]

Phrase: "regulate"

Phrase: "the phosphorylation of brain Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "GSK3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.88: The first group of experiments employed streptozotocin treatment to induce hyperglycemia resulting from insulin depletion. 

Phrase: "The first group of experiments"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "streptozotocin treatment to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "resulting from insulin depletion."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0333668:Depletion [Functional Concept]
   770   C0678226:resulting [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.89: Streptozotocin administered to mice causes a rapid degeneration of insulin-producing -cells of the pancreas, resulting in greatly diminished production of insulin and a resultant elevation of blood glucose levels. 

Phrase: "Streptozotocin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "administered to mice"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C1521801:Administered [Functional Concept]
   756 E C1621583:Administer [Functional Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a rapid degeneration of insulin-producing -cells of the pancreas,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0333467:cells degeneration [Pathologic Function]
   739   C0011164:Degeneration [Pathologic Function]
   739   C1880269:Degeneration [Functional Concept]

Phrase: "resulting in greatly diminished production of insulin"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0332294:Resulting in [Functional Concept]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0033268:production [Occupational Activity]
   748   C0205216:Diminished [Quantitative Concept]
   748   C0678226:resulting [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "a resultant elevation of blood glucose levels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439775:Elevation [Therapeutic or Preventive Procedure]
   748   C0702240:Elevation [Spatial Concept]
Processing 00000000.tx.90: Three days after streptozotocin treatment, insulin levels were reduced to 28  2% of control levels (TABLE TWO). 

Phrase: "Three days after streptozotocin treatment,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0439228:days [Temporal Concept]
   726 E C0332173:/day [Temporal Concept]
   726 E C0439505:/day [Temporal Concept]

Phrase: "insulin levels"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0202098:insulin levels [Laboratory Procedure]
  1000   C0428405:insulin levels [Laboratory or Test Result]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "reduced to 28  2% of control levels"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   757   C0456948:Level 2 [Intellectual Product]
   748   C0243148:control [Qualitative Concept]
   748   C0392756:Reduced [Qualitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "(TABLE TWO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.91: Concurrently, blood glucose levels were elevated to 304  6% of control levels. 

Phrase: "Concurrently,"

Phrase: "blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "were"

Phrase: "elevated to 304  6% of control levels."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   748   C0205250:Elevated [Qualitative Concept]
   748   C0243148:control [Qualitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3163633:Elevated [Qualitative Concept]
   748   C3274648:Control [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.92: The body weights but not temperatures of streptozotocin-treated mice were significantly different from controls. 

Phrase: "The body weights"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0005910:Weights, Body [Organism Attribute]
       E   weight
  1000   C1305866:body weights [Diagnostic Procedure]
       E   weight
   861   C0043100:Weights [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   827 E C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "but"

Phrase: "not temperatures of streptozotocin-treated mice"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0039476:Temperatures [Quantitative Concept]
   719 E C0005903:temperature [Organism Attribute]

Phrase: "were"

Phrase: "significantly different from controls."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.93: Three days after streptozotocin administration the phosphorylation of Akt at both Thr308 and Ser473 was significantly increased above the control levels in both the cerebral cortex and the hippocampus (Fig. 4A). 

Phrase: "Three days after streptozotocin administration"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0439228:days [Temporal Concept]
   726 E C0332173:/day [Temporal Concept]
   726 E C0439505:/day [Temporal Concept]

Phrase: "the phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "at both Thr308"

Phrase: "and"

Phrase: "Ser473"

Phrase: "was"

Phrase: "significantly"

Phrase: "increased above the control levels"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0205217:Increased [Quantitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in both"

Phrase: "the cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.94: There were no differences in the total protein level of Akt in either brain region. 

Phrase: "There"

Phrase: "were"

Phrase: "no differences in the total protein level of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1705241:*Difference [Quantitative Concept]
   708   C1705242:Difference [Qualitative Concept]

Phrase: "in either brain region."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C1273723:Brain region [Body Location or Region]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.95: There were similarly large increases in the serine phosphorylation levels of GSK3 and GSK3 3 days following streptozotocin treatment in both the cerebral cortex and hippocampus (Fig. 4B). 

Phrase: "There"

Phrase: "were"

Phrase: "similarly large increases in the serine phosphorylation levels of GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "GSK3 3 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   799   C0439228:days [Temporal Concept]
   766 E C0332173:/day [Temporal Concept]
   766 E C0439505:/day [Temporal Concept]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "streptozotocin treatment in both"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "the cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.96: There were no changes in tyrosine phosphorylation, and total levels of GSK3 in either brain region 3 days after administration of streptozotocin. 

Phrase: "There"

Phrase: "were"

Phrase: "no changes in tyrosine phosphorylation,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0442739:No change [Finding]
   790   C1548568:No change [Intellectual Product]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "total levels of GSK3"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456949:Level 3 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in either brain region 3 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0439228:days [Temporal Concept]
   771 E C0332173:/day [Temporal Concept]
   771 E C0439505:/day [Temporal Concept]

Phrase: "after administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001554:Administration [Occupational Activity]
  1000   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "of streptozotocin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
Processing 00000000.tx.97: These results further underscore the conclusion that the circulating glucose concentration regulates brain Akt and GSK3 phosphorylation because insulin was reduced but glucose was elevated in association with the increases in Akt and GSK3 phosphorylation. 

Phrase: "These results further"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "underscore"

Phrase: "the conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "that"

Phrase: "the circulating glucose concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0427743:Glucose concentration [Laboratory Procedure]
   901   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "regulates"

Phrase: "brain Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3 phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "because"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "but"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "elevated in association"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0004083:Association [Mental Process]
   790   C0205250:Elevated [Qualitative Concept]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]
   790   C3163633:Elevated [Qualitative Concept]

Phrase: "with the increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:increases [Functional Concept]

Phrase: "in Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3 phosphorylation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.98: Thus, these results show that short term pathological hyperglycemia caused large increases in the regulatory phosphorylation states of brain Akt and GSK3. 

Phrase: "Thus,"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that short term pathological hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "large increases in the regulatory phosphorylation states of brain Akt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "GSK3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.99: View larger version (29K): [in this window] [in a new window]  FIGURE 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 3."
Processing 00000000.tx.100: Insulin transiently increases the phosphorylation of Akt and GSK3 in mouse brain. 

Phrase: "Insulin transiently"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "GSK3 in mouse brain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.101: Food was withdrawn overnight and after an ip injection of 5 international units/kg insulin, blood glucose and serum insulin concentrations were measured (A), and protein extracts from the cerebral cortex and hippocampus were immunoblotted for Phospho-Thr308-Akt, Phospho-Ser473-Akt, and Total Akt (B), and Phospho-Ser21-GSK3, Phospho-Ser9-GSK3, Phospho-Tyr279/216-GSK3/, and Total GSK3/ (C). 

Phrase: "Food"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "was"

Phrase: "withdrawn"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0424092:Withdrawn [Finding]
  1000   C2349954:Withdrawn [Activity]
  1000   C2825032:Withdrawn [Mental or Behavioral Dysfunction]

Phrase: "overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "and after an ip injection of 5 international units/kg insulin,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   772   C0199782:Injection of insulin [Therapeutic or Preventive Procedure]
           Insulin injection
   756   C0439453:international units [Quantitative Concept]
   754   C0586328:Insulin injection [Therapeutic or Preventive Procedure]
   739   C1300561:unit/kg [Quantitative Concept]
   738   C0021485:injection [Therapeutic or Preventive Procedure]
   738   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C0022718:KG [Geographic Area]
   738   C0439148:Units [Quantitative Concept]
   738   C0439209:kg [Quantitative Concept]
   738   C1272883:Injection [Biomedical or Dental Material]
   738   C1512888:International [Idea or Concept]
   738   C1515981:And [Idea or Concept]
   738   C1519795:Units [Quantitative Concept]
   738   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C1533685:Injection [Therapeutic or Preventive Procedure]
   738   C1579433:Insulin [Pharmacologic Substance]
   738   C1828121:Injection [Functional Concept]
   704 E C1704753:Unit [Manufactured Object]
   704 E C1880519:Unit [Quantitative Concept]

Phrase: "blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "serum insulin concentrations"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   896   C0683149:serum concentration [Quantitative Concept]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0428357:Serum insulin [Laboratory Procedure]
   734   C1261415:serum insulin [Laboratory or Test Result]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extracts from the cerebral cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]
   760   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "immunoblotted for Phospho-Thr308-Akt,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0812228:AKT [Gene or Genome]
   726   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "Phospho-Ser473-Akt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "Total Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Phospho-Ser21-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Phospho-Ser9-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Phospho-Tyr279/216-GSK3/,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   877   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   845   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Total GSK3/"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.102: Quantitative values were obtained by densitometric measurements of immunoblots and are means  S.E. from three mice per group.  

Phrase: "Quantitative values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "obtained by densitometric measurements of immunoblots"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0242485:measurements [Functional Concept]
   753   C1301820:Obtained [Functional Concept]
   719   C0020985:Immunoblot [Laboratory Procedure]
   719 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "are"

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from three mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "per group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.103: View this table: [in this window] [in a new window]  TABLE TWO Body weight, blood glucose, serum insulin, and body temperature of control mice and of mice 3 days after steptozotocin treatment  To ensure that streptozotocin-induced insulin depletion decreased signaling by insulin receptors, epididymal fat samples were examined as a control tissue. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE TWO Body weight,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   861   C0005910:Body Weight [Organism Attribute]
           weight
   861   C1305866:body weight [Diagnostic Procedure]
           weight
   812   C0043100:Weight [Quantitative Concept]
   812   C0242821:body [Human]
   812   C0460148:Body [Anatomical Structure]
   812   C1268086:Body [Anatomical Structure]
   812   C1705104:Weight [Idea or Concept]
   729 E C1995017:Bodies [Cell Component]

Phrase: "blood glucose,"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "serum insulin,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0428357:Serum insulin [Laboratory Procedure]
  1000   C1261415:serum insulin [Laboratory or Test Result]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "body temperature of control mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0005903:Body Temperature [Organism Attribute]
           temperature
   760   C0039476:*Temperature [Quantitative Concept]
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]

Phrase: "and of mice 3 days"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0439228:days [Temporal Concept]
   760   C1515981:And [Idea or Concept]
   726 E C0332173:/day [Temporal Concept]
   726 E C0439505:/day [Temporal Concept]

Phrase: "after steptozotocin treatment  To"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that streptozotocin-induced insulin depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0333668:Depletion [Functional Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "signaling by insulin receptors,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1514762:Receptor Signaling [Molecular Function]
   770   C0037083:Signaling [Cell Function]
   770   C3537152:signaling [Biologic Function]

Phrase: "epididymal fat samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "examined as a control tissue."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0040300:Tissue [Tissue]
   760   C0243148:control [Qualitative Concept]
   760   C0332128:Examined [Finding]
   760   C1547928:Tissue [Intellectual Product]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.104: As expected, and in marked contrast to brain tissue, 3 days after streptozotocin treatment epididymal fat displayed large decreases in the levels of phospho-Thr308-Akt and phospho-Ser473-Akt, whereas the total levels of Akt remained unchanged (Fig. 5A). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "and in marked contrast"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0522501:Marked [Qualitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C1706089:Marked [Qualitative Concept]
   770   C1979874:Contrast [Qualitative Concept]

Phrase: "to brain tissue,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0440746:Brain tissue [Tissue]
  1000   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0040300:Tissue [Tissue]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "3 days after streptozotocin treatment epididymal fat"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   778   C1442459:3 Days [Temporal Concept]
   748   C0439228:days [Temporal Concept]
   714 E C0332173:/day [Temporal Concept]
   714 E C0439505:/day [Temporal Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "large decreases in the levels of phospho-Thr308-Akt"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0547047:decreases [Quantitative Concept]
   708 E C0392756:Decrease [Qualitative Concept]

Phrase: "and"

Phrase: "phospho-Ser473-Akt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "whereas"

Phrase: "the total levels of Akt"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "remained"

Phrase: "unchanged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.105: There were also large decreases in phospho-Ser21-GSK3 and phospho-Ser9-GSK3 in fat from treated mice compared with controls, but no changes in the tyrosine-phosphorylated or total levels of GSK3 (Fig. 5B). 

Phrase: "There"

Phrase: "were"

Phrase: "also large decreases in phospho-Ser21-GSK3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0547047:decreases [Quantitative Concept]
   706 E C0392756:Decrease [Qualitative Concept]

Phrase: "and"

Phrase: "phospho-Ser9-GSK3 in fat"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "from treated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "compared with controls,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "but"

Phrase: "no changes in the tyrosine-phosphorylated"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   773   C0442739:No change [Finding]
   773   C1548568:No change [Intellectual Product]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "or"

Phrase: "total levels of GSK3"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456949:Level 3 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.106: Thus, the phosphorylation of Akt and GSK3 in fat exhibited the large decreases predicted to occur following insulin depletion. 

Phrase: "Thus,"

Phrase: "the phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "GSK3 in fat"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "the large decreases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0547047:decreases [Quantitative Concept]
   827 E C0392756:Decrease [Qualitative Concept]

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "insulin depletion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333668:Depletion [Functional Concept]
Processing 00000000.tx.107: The activities of Akt and GSK3 were measured in cerebral cortex and epididymal fat 3 days after streptozotocin treatment to ensure that changes in phosphorylation levels reflected altered kinase activities, as has been well documented previously for each enzyme. 

Phrase: "The activities of Akt"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441655:Activities [Activity]
   737 E C0205177:Activity [Functional Concept]
   737 E C0439167:% activity [Quantitative Concept]
   737 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "measured in cerebral cortex"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   770   C0444706:Measured [Qualitative Concept]
   770   C1176472:Cortex [Body Part, Organ, or Organ Component]
   770   C2700441:Cortex [Plant]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "epididymal fat 3 days after streptozotocin treatment to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0439228:days [Temporal Concept]
   711 E C0332173:/day [Temporal Concept]
   711 E C0439505:/day [Temporal Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that changes in phosphorylation levels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "reflected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflected [Mental Process]

Phrase: "altered kinase activities,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   884   C1150423:kinase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "well documented previously for each enzyme."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0205170:Well [Qualitative Concept]
   753   C1301725:Documented [Health Care Activity]
   753   C1609436:documented [Idea or Concept]
   753   C3146287:Well [Manufactured Object]
   719 E C1301746:document [Intellectual Product]
   719 E C1547673:Document [Intellectual Product]
Processing 00000000.tx.108: Three days after streptozotocin treatment, Akt activity was increased in the cerebral cortex by 2.5-fold concurrently with the increased levels of phospho-Thr308- and phospho-Ser473-Akt in the same samples (Fig. 6A). 

Phrase: "Three days after streptozotocin treatment,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0439228:days [Temporal Concept]
   726 E C0332173:/day [Temporal Concept]
   726 E C0439505:/day [Temporal Concept]

Phrase: "Akt activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "increased in the cerebral cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]

Phrase: "by 2.5-fold concurrently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332462:Fold [Spatial Concept]
   812   C1880834:FOLD [Phenomenon or Process]

Phrase: "with the increased levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of phospho-Thr308-"

Phrase: "and"

Phrase: "phospho-Ser473-Akt in the same samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0812228:AKT [Gene or Genome]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.109: Conversely, in the same animals epididymal fat exhibited a greater than 50% decrease in Akt activity which correlated with the decreased dual phosphorylation of Akt evident in immunoblots. 

Phrase: "Conversely,"

Phrase: "in the same animals epididymal fat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0301429:Animal fat [Lipid,Pharmacologic Substance]
   812   C0424612:FAT [Organism Attribute]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a greater than 50% decrease"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0439093:Greater Than [Quantitative Concept]
   760   C0443228:greater [Quantitative Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "in Akt activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "which"

Phrase: "correlated with the decreased dual phosphorylation of Akt"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205216:Decreased [Quantitative Concept]
   744   C0392756:Decreased [Qualitative Concept]
   744   C0442797:decreased [Qualitative Concept]
   744   C0812228:AKT [Gene or Genome]
   744   C1158886:Phosphorylation [Molecular Function]
   744   C1554184:Dual [Intellectual Product]
   744   C1707520:Correlated [Qualitative Concept]
   711 E C0547047:Decrease [Quantitative Concept]

Phrase: "evident in immunoblots."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.110: In accordance with the well known inhibitory effect of N-terminal serine phosphorylation of GSK3 activity, after streptozotocin treatment, the activities of GSK3 and GSK3 were increased in fat where serine phosphorylation was decreased. 

Phrase: "In accordance with the well known inhibitory effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1280500:Effect [Qualitative Concept]
   812   C2348382:Effect [Qualitative Concept]

Phrase: "of N-terminal serine phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "of GSK3 activity,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   933   C2261482:glycogen synthase kinase activity [Molecular Function]
   911   C1152133:glycogen synthase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "after"

Phrase: "streptozotocin treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "the activities of GSK3"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   863   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   823   C2261482:glycogen synthase kinase activity [Molecular Function]
   788   C1152133:glycogen synthase activity [Molecular Function]
   757   C1150423:kinase activity [Molecular Function]
   748   C0441655:Activities [Activity]
   714 E C0205177:Activity [Functional Concept]
   714 E C0439167:% activity [Quantitative Concept]
   714 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "increased in fat where serine phosphorylation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0205217:Increased [Quantitative Concept]
   753   C0424612:FAT [Organism Attribute]
   753   C0442805:Increased [Functional Concept]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "decreased."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.111: The activities were decreased in the cerebral cortex where serine phosphorylation of GSK3 was increased (Fig. 6B). 

Phrase: "The activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441655:Activities [Activity]
   966 E C0205177:Activity [Functional Concept]
   966 E C0439167:% activity [Quantitative Concept]
   966 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "decreased in the cerebral cortex where serine phosphorylation of GSK3"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   784   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   766   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   750   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   750   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   749   C0072402:Serine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   749   C1291109:Decreased glycogen [Finding]
   735   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   735   C0031715:Phosphorylation [Molecular Function]
   735   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   735   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   735   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   735   C0205216:Decreased [Quantitative Concept]
   735   C0392756:Decreased [Qualitative Concept]
   735   C0442797:decreased [Qualitative Concept]
   735   C1158886:Phosphorylation [Molecular Function]
   735   C1176472:Cortex [Body Part, Organ, or Organ Component]
   735   C2700441:Cortex [Plant]
   702 E C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.112: These results confirm that the phosphorylation levels of Akt and GSK3 reflect their enzymatic activities in both fat and brain tissue. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the phosphorylation levels of Akt"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "their enzymatic activities in both fat"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   773   C2267219:Enzymatic Activity [Molecular Function]
   753   C0441655:Activities [Activity]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "brain tissue."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0440746:Brain tissue [Tissue]
  1000   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0040300:Tissue [Tissue]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   861   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.113: The effects of sustained streptozotocin-induced hyperglycemia were measured by examining phosphorylation levels of Akt and GSK3 in the brain 4 weeks after streptozotocin treatment. 

Phrase: "The effects of sustained streptozotocin-induced hyperglycemia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "measured by examining phosphorylation levels of Akt"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0332128:examining [Finding]
   748   C0441889:Levels [Qualitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0812228:AKT [Gene or Genome]
   748   C1158886:Phosphorylation [Molecular Function]
   748   C2004054:Examining [Activity]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "GSK3 in the brain 4 weeks"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "after streptozotocin treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.114: Large increases in the levels of phospho-Ser473-Akt and phospho-Thr308-Akt were present in both the cerebral cortex and hippocampus of mice 4 weeks after treatment with streptozotocin (Fig. 7A). 

Phrase: "Large increases in the levels of phospho-Ser473-Akt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "phospho-Thr308-Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "were"

Phrase: "present in both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "the cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "hippocampus of mice 4 weeks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C1523990:Mouse Hippocampus [Tissue]
   760   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   760   C0949582:Hippocampus [Fish]
   760   C1029104:Hippocampus [Fish]
   760   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "after treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with streptozotocin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.115: These mice also displayed increased levels of phospho-Ser21-GSK3 and phospho-Ser9-GSK3 in both brain regions (Fig. 7B). 

Phrase: "These mice also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "increased levels of phospho-Ser21-GSK3"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   745   C0456949:Level 3 [Intellectual Product]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "phospho-Ser9-GSK3 in both brain regions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.116: Quantitation of the phosphorylation levels in four mice per group revealed statistically significant increases ranging from 210-fold in samples from streptozotocin-treated mice compared with control mice. 

Phrase: "Quantitation of the phosphorylation levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantitation [Quantitative Concept]

Phrase: "in four mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "per group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "statistically significant increases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0442805:increases [Functional Concept]
   734   C0237881:statistically significant [Quantitative Concept]

Phrase: "ranging from 210-fold"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0332462:Fold [Spatial Concept]
   770   C1880834:FOLD [Phenomenon or Process]
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "in samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "from streptozotocin-treated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "compared with control mice."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.117: In contrast to the large increases in serine phosphorylation of GSK3, tyrosine phosphorylation and total levels of both GSK3 and GSK3 were not affected by long term streptozotocin treatment. 

Phrase: "In contrast to the large increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:increases [Functional Concept]

Phrase: "in serine phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "of GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "tyrosine phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519726:Tyrosine Phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "total levels of both GSK3"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C0456949:Level 3 [Intellectual Product]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by long term streptozotocin treatment."
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   820   C0023977:long-term treatment [Health Care Activity]
   790   C0443252:Long-term [Temporal Concept]
   753   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0205166:Long [Qualitative Concept]
   753   C0392760:Affected [Functional Concept]
   753   C1314939:Affected [Functional Concept]
   753   C1515273:Term [Temporal Concept]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C1705313:Term [Idea or Concept]
   753   C1706317:Long [Qualitative Concept]
   753   C2826302:TERM [Intellectual Product]
   753   C3538994:TREATMENT [Research Activity]
   719 E C0001721:Affect [Mental Process]
Processing 00000000.tx.118: Thus, hyperglycemia caused by streptozotocin treatment caused both short and long term large increases in the phosphorylation states of Akt and GSK3 in both brain regions. 

Phrase: "Thus,"

Phrase: "hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "caused by streptozotocin treatment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "both short"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1282927:short [Qualitative Concept]
  1000   C1806781:Short [Quantitative Concept]
  1000   C2350002:Short [Quantitative Concept]

Phrase: "and"

Phrase: "long term large increases in the phosphorylation states of Akt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "GSK3 in both brain regions."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.119: View larger version (40K): [in this window] [in a new window]  FIGURE 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(40K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 4."
Processing 00000000.tx.120: Streptozotocin administration rapidly increases the phosphorylation of Akt and GSK3 in mouse brain. 

Phrase: "Streptozotocin administration rapidly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001554:Administration [Occupational Activity]
   827   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "GSK3 in mouse brain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.121: Mice were treated with streptozotocin, and after 3 days, protein extracts from the cerebral cortex and hippocampus were immunoblotted for Phospho-Thr308-Akt, Phospho-Ser473-Akt, and Total Akt (A), and Phospho-Ser21-GSK3, Phospho-Ser9-GSK3, Phospho-Tyr279/216-GSK3/, and Total GSK3/ (B). 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "treated with streptozotocin,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "and after 3 days,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0439228:days [Temporal Concept]
   770   C1515981:And [Idea or Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extracts from the cerebral cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]
   760   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "immunoblotted for Phospho-Thr308-Akt,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0812228:AKT [Gene or Genome]
   726   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "Phospho-Ser473-Akt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "Total Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Phospho-Ser21-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Phospho-Ser9-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Phospho-Tyr279/216-GSK3/,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   877   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   845   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Total GSK3/"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.122: C, control; 

Phrase: "C,"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.123: S, streptozotocin-treated. 

Phrase: "S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "streptozotocin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "treated."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.124: Quantitative values were obtained by densitometric measurements of immunoblots and are means  S.E. from four mice per group. 

Phrase: "Quantitative values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "obtained by densitometric measurements of immunoblots"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0242485:measurements [Functional Concept]
   753   C1301820:Obtained [Functional Concept]
   719   C0020985:Immunoblot [Laboratory Procedure]
   719 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "are"

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from four mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "per group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.125: *, p < 0.05 compared with control values.  

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with control values."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0042295:Values [Qualitative Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.126: View larger version (61K): [in this window] [in a new window]  FIGURE 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(61K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 5."
Processing 00000000.tx.127: Streptozotocin administration rapidly decreases the phosphorylation of Akt and GSK3 in mouse epididymal fat. 

Phrase: "Streptozotocin administration rapidly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001554:Administration [Occupational Activity]
   827   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "GSK3 in mouse epididymal fat."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.128: Mice were treated with streptozotocin, and after 3 days, protein extracts from epididymal fat were immunoblotted for Phospho-Thr308-Akt, Phospho-Ser473-Akt, and Total Akt (A), and Phospho-Ser21-GSK3, Phospho-Ser9-GSK3, Phospho-Tyr279/216-GSK3/, and total GSK3/ (B). 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "treated with streptozotocin,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "and after 3 days,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0439228:days [Temporal Concept]
   770   C1515981:And [Idea or Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extracts from epididymal fat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0014533:Epididymal [Body Part, Organ, or Organ Component]
   770   C0424612:FAT [Organism Attribute]
   770   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "immunoblotted for Phospho-Thr308-Akt,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0812228:AKT [Gene or Genome]
   726   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "Phospho-Ser473-Akt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "Total Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Phospho-Ser21-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Phospho-Ser9-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Phospho-Tyr279/216-GSK3/,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   877   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   845   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "total GSK3/"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.129: C, control; 

Phrase: "C,"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.130: S, streptozotocin-treated.  

Phrase: "S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "streptozotocin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "treated."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.131: To determine if the phosphorylation levels Akt and GSK3 in the brain were increased in a second mouse model of diabetes associated with hyperglycemia, male db/db mice that develop an insulin resistance phenotype (22), were examined. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "the phosphorylation levels Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3 in the brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "increased in a second mouse model of diabetes"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C2986594:Mouse Model [Experimental Model of Disease]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0205217:Increased [Quantitative Concept]
   744   C0205436:Second [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C0457385:Second [Temporal Concept]
   744   C0565930:/second [Quantitative Concept]
   744   C1561503:second [Idea or Concept]
   744   C1705190:Second [Qualitative Concept]
   744   C3161035:Model [Intellectual Product]

Phrase: "associated with hyperglycemia,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0020456:Hyperglycaemia [Disease or Syndrome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "male db/db mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "develop"

Phrase: "an insulin resistance phenotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]
   734   C0021655:Insulin Resistance [Pathologic Function]
   734   C2700570:INSULIN RESISTANCE [Gene or Genome]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.132: The db/db mice were hyperglycemic and insulinopenic, with blood glucose concentrations 390  7% of control levels and insulin concentrations 280  12% of controls, and their body weights were significantly increased (TABLE THREE). 

Phrase: "The db/db mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "hyperglycemic"

Phrase: "and"

Phrase: "insulinopenic,"

Phrase: "with blood glucose concentrations 390  7%"
Meta Candidates (Total=21; Excluded=9; Pruned=0; Remaining=12)
   867   C2585282:Blood glucose concentration [Finding]
   853   C0427728:blood concentrations [Laboratory or Test Result]
   853   C0699870:blood concentrations [Quantitative Concept]
   853   C1313904:blood concentrations [Laboratory Procedure]
   840   C0005802:Blood Glucose [Carbohydrate]
   823   C0427743:Glucose concentration [Laboratory Procedure]
   823   C1287281:Glucose concentration [Laboratory or Test Result]
   804   C0005767:Blood [Tissue]
   804   C0005768:blood [Body Substance]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0086045:Concentrations [Mental Process]
   804   C0229664:Blood [Body Substance]
   771 E C1446561:Concentration [Quantitative Concept]
   733 E C0333275:Bloody [Qualitative Concept]
   721 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   721 E C0392895:Bloods [Population Group]
   721 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   721 E C1511228:VESSEL, BLOOD [Tissue]
   721 E C1880165:Concentrated [Biomedical or Dental Material]
   704 E C1558950:VASCULAR [Finding]
   704 E C1801960:Vascular [Qualitative Concept]

Phrase: "of control levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0243148:control [Qualitative Concept]
   861   C0441889:Levels [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin concentrations 280  12% of controls,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0086045:Concentrations [Mental Process]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   719   C0243148:control [Qualitative Concept]
   719 E C1446561:Concentration [Quantitative Concept]
   719   C1550141:Control [Substance]
   719   C1882979:Control [Conceptual Entity]
   719   C2587213:Control [Functional Concept]
   719   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "their body weights"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0005910:Weights, Body [Organism Attribute]
       E   weight
  1000   C1305866:body weights [Diagnostic Procedure]
       E   weight
   861   C0043100:Weights [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   827 E C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "were"

Phrase: "significantly"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(TABLE THREE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0039224:Table [Manufactured Object]
   861   C0205449:Three [Quantitative Concept]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.133: In db/db mice, compared with control mice, there were large increases in phospho-Thr308-Akt and phospho-Ser473-Akt (Fig. 8A) and in phospho-Ser21-GSK3 and phospho-Ser9-GSK3 (Fig. 8B) in the cerebral cortex and hippocampus. 

Phrase: "In db/db mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "compared with control mice,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "there"

Phrase: "were"

Phrase: "large increases in phospho-Thr308-Akt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "phospho-Ser473-Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "(Fig. 8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553640:8a [Medical Device]

Phrase: ")"

Phrase: "and in phospho-Ser21-GSK3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "phospho-Ser9-GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: ")"

Phrase: "in the cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "hippocampus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.134: There were no differences in total protein levels of Akt or GSK3 in db/db brain regions compared with controls. 

Phrase: "There"

Phrase: "were"

Phrase: "no differences in total protein levels of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "GSK3 in db/db brain regions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "compared with controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.135: These results show that in two mouse models of diabetes, hyperglycemia was associated with large chronic increases in the phosphorylation states of Akt and GSK3 in the brain. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that in two mouse"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0205448:Two [Quantitative Concept]

Phrase: "models of diabetes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C3161035:Model [Intellectual Product]

Phrase: "hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "was"

Phrase: "associated with large chronic increases"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0205191:chronic [Temporal Concept]
   760   C0442805:increases [Functional Concept]
   760   C0549177:Large [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the phosphorylation states"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
   861   C1301808:states [Geographic Area]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]

Phrase: "of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3 in the brain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.136: View this table: [in this window] [in a new window]  TABLE THREE Body weight, blood glucose, and serum insulin of control and db/db mice  To test if the hyperglycemic-induced increases in phosphorylation of brain Akt and GSK3 could be reversed by lowering the glucose level, and to confirm that the glucose was regulatory, 3 days after streptozotocin treatment, blood glucose levels were reduced by acute insulin treatment. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE THREE Body weight,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   861   C0005910:Body Weight [Organism Attribute]
           weight
   861   C1305866:body weight [Diagnostic Procedure]
           weight
   812   C0043100:Weight [Quantitative Concept]
   812   C0242821:body [Human]
   812   C0460148:Body [Anatomical Structure]
   812   C1268086:Body [Anatomical Structure]
   812   C1705104:Weight [Idea or Concept]
   729 E C1995017:Bodies [Cell Component]

Phrase: "blood glucose,"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "serum insulin of control"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0428357:Serum insulin [Laboratory Procedure]
   833   C1261415:serum insulin [Laboratory or Test Result]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "db/db mice  To"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "if"

Phrase: "the hyperglycemic-induced increases in phosphorylation of brain Akt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "could"

Phrase: "be"

Phrase: "reversed by lowering"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0441994:lowering [Spatial Concept]
   790   C2003888:Lowering [Activity]
   756 E C1548802:Lower [Body Location or Region]
   756   C1555029:Reverse [Idea or Concept]

Phrase: "the glucose level,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0337438:glucose level [Laboratory Procedure]
  1000   C0428548:Glucose level [Laboratory or Test Result]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "regulatory, 3 days after streptozotocin treatment,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0439228:days [Temporal Concept]
   719 E C0332173:/day [Temporal Concept]
   719 E C0439505:/day [Temporal Concept]

Phrase: "blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "were"

Phrase: "reduced by acute insulin treatment."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   806   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0205178:acute [Temporal Concept]
   760   C0392756:Reduced [Qualitative Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.137: Administration of 5 international units/kg insulin caused a rapid increase in blood insulin and a corresponding decrease in blood glucose (Fig. 9A). 

Phrase: "Administration of 5 international units/kg insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0199782:Administration of insulin [Therapeutic or Preventive Procedure]
           administration insulin
   748   C0001554:Administration [Occupational Activity]
   748   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a rapid increase in blood insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0020459:INSULIN INCREASE [Disease or Syndrome]
   753   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "a corresponding decrease in blood glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "(Fig. 9A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553641:9a [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.138: Insulin treatment resulted in decreases in the dual phosphorylation of Akt (Fig. 9A) and in the serine phosphorylation of both GSK3 isoforms (Fig. 9B). 

Phrase: "Insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "resulted in decreases"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0547047:decreases [Quantitative Concept]
   756 E C0392756:Decrease [Qualitative Concept]
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "in the dual phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "(Fig. 9A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553641:9a [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "and in the serine phosphorylation of both GSK3 isoforms"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   751   C0072402:Serine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   736   C0031715:Phosphorylation [Molecular Function]
   736   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   736   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   736   C1158886:Phosphorylation [Molecular Function]
   736   C1515981:And [Idea or Concept]

Phrase: "(Fig. 9B"

Phrase: ")."
Processing 00000000.tx.139: These results show that the increased phosphorylation of Akt and GSK3 in the brain caused by streptozotocin-induced hyperglycemia could be rapidly reversed by lowering the blood glucose concentration. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the increased phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "GSK3 in the brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "caused by streptozotocin-induced hyperglycemia"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0020456:Hyperglycaemia [Disease or Syndrome]
   760   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   760   C0205263:Induced [Functional Concept]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]

Phrase: "could"

Phrase: "be"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "reversed by lowering"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0441994:lowering [Spatial Concept]
   790   C2003888:Lowering [Activity]
   756 E C1548802:Lower [Body Location or Region]
   756   C1555029:Reverse [Idea or Concept]

Phrase: "the blood glucose concentration."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C2585282:Blood glucose concentration [Finding]
   913   C0427728:Blood concentration [Laboratory or Test Result]
   913   C0699870:blood concentration [Quantitative Concept]
   913   C1313904:Blood concentration [Laboratory Procedure]
   901   C0427743:Glucose concentration [Laboratory Procedure]
   901   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0005802:Blood Glucose [Carbohydrate]
Processing 00000000.tx.140: View larger version (42K): [in this window] [in a new window]  FIGURE 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(42K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 6."
Processing 00000000.tx.141: Effects of streptozotocin treatment on activities of Akt and GSK3. 

Phrase: "Effects of streptozotocin treatment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C1518681:Treatment Effect [Finding]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441655:Activities [Activity]
   966 E C0205177:Activity [Functional Concept]
   966 E C0439167:% activity [Quantitative Concept]
   966 E C1561536:*Activity [Idea or Concept]

Phrase: "of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.142: Mice were treated with streptozotocin, and after 3 days the cerebral cortex and epididymal fat were obtained. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "treated with streptozotocin,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "and after 3 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0439228:days [Temporal Concept]
   770   C1515981:And [Idea or Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "the cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "epididymal fat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0424612:FAT [Organism Attribute]

Phrase: "were"

Phrase: "obtained."
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.143: A, Akt activity and levels of Phospho-Thr308-Akt, Phospho-Ser473-Akt, and Total Akt were measured in the same mice. 

Phrase: "A,"

Phrase: "Akt activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "levels of Phospho-Thr308-Akt,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "Phospho-Ser473-Akt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "Total Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "were"

Phrase: "measured in the same mice."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0444706:Measured [Qualitative Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.144: B, GSK3 and GSK3 activities and levels of Phospho-Ser21-GSK3, Phospho-Ser9-GSK3, and Total GSK3/ were measured in the same mice.   

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "GSK3 activities"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   983   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   916   C2261482:glycogen synthase kinase activity [Molecular Function]
   894   C1152133:glycogen synthase activity [Molecular Function]
   836   C1150423:kinase activity [Molecular Function]
   804   C0441655:Activities [Activity]
   771 E C0205177:Activity [Functional Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   771 E C0439167:% activity [Quantitative Concept]
   771 E C1561536:*Activity [Idea or Concept]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "levels of Phospho-Ser21-GSK3,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C0456949:Level 3 [Intellectual Product]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "Phospho-Ser9-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Total GSK3/"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "measured in the same mice."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0444706:Measured [Qualitative Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.145: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  This investigation found a surprisingly strong role for physiological and pathological changes in the circulating concentration of glucose, in addition to insulin, in regulating the Akt-GSK3 signaling pathway in mouse brain. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1261322:Investigation [Health Care Activity]
  1000   C1552578:investigation [Idea or Concept]
   928 E C1517586:Investigational [Qualitative Concept]
   928 E C3245491:investigational [Intellectual Product]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "a surprisingly strong role for physiological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "pathological changes in the circulating concentration of glucose,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "in addition to insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in"

Phrase: "regulating"

Phrase: "the Akt-GSK3 signaling pathway in mouse brain."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   772   C1515844:AKT Signaling Pathway [Molecular Function]
   756   C0037083:signaling pathway [Cell Function]
   756   C0086982:Signaling Pathway [Molecular Function]
   754 E C0037080:pathway signaling [Molecular Function]
   754   C0815011:brain pathway [Body Part, Organ, or Organ Component]
   738   C1704259:Pathway [Molecular Function]
   738   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.146: In both the cerebral cortex and the hippocampus, the phosphorylation states of Akt and GSK3 were found to be influenced by physiological fluctuations in the blood glucose concentration, by acutely administered glucose or insulin, by short term (3 days) and long term (4 weeks) hyperglycemia caused by pathological insulin depletion after streptozotocin administration, and by hyperglycemia linked to insulin resistance in type 2 diabetic db/db mice. 

Phrase: "In both"

Phrase: "the cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "the hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "the phosphorylation states of Akt"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C1301808:states [Geographic Area]
   726 E C1442792:State [Functional Concept]
   726 E C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "influenced by physiological fluctuations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205463:Physiological [Functional Concept]
   770   C0231239:fluctuations [Sign or Symptom]
   737 E C0231241:Fluctuation [Temporal Concept]
   737 E C2827773:Fluctuation% [Qualitative Concept]

Phrase: "in the blood glucose concentration,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C2585282:Blood glucose concentration [Finding]
   913   C0427728:Blood concentration [Laboratory or Test Result]
   913   C0699870:blood concentration [Quantitative Concept]
   913   C1313904:Blood concentration [Laboratory Procedure]
   901   C0427743:Glucose concentration [Laboratory Procedure]
   901   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0005802:Blood Glucose [Carbohydrate]

Phrase: "by acutely administered glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "or"

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "by short term"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0443303:Short-term [Temporal Concept]
   861   C1282927:short [Qualitative Concept]
   861   C1515273:Term [Temporal Concept]
   861   C1705313:Term [Idea or Concept]
   861   C1806781:Short [Quantitative Concept]
   861   C2350002:Short [Quantitative Concept]
   861   C2826302:TERM [Intellectual Product]

Phrase: "(3 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442459:3 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "long term"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0443252:Long-term [Temporal Concept]
   861   C0205166:Long [Qualitative Concept]
   861   C1515273:Term [Temporal Concept]
   861   C1705313:Term [Idea or Concept]
   861   C1706317:Long [Qualitative Concept]
   861   C2826302:TERM [Intellectual Product]

Phrase: "(4 weeks"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442465:4 Weeks [Temporal Concept]
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: ")"

Phrase: "hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "caused by pathological insulin depletion"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0030664:Pathological [Biomedical Occupation or Discipline]
   760   C0333668:Depletion [Functional Concept]
   760   C1521733:Pathological [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "after streptozotocin administration,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001554:Administration [Occupational Activity]
   861   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "and by hyperglycemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020456:Hyperglycaemia [Disease or Syndrome]
   790   C1515981:And [Idea or Concept]

Phrase: "linked to insulin resistance"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   783   C0332325:Resistant to [Functional Concept]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in type 2 diabetic db/db mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
Processing 00000000.tx.147: Hyperglycemia in the presence of normal or deficient insulin levels caused large increases in the phosphorylation levels of Akt and GSK3 in the brain, as did acute insulin administration, whereas they were reduced by fasting-induced hypoglycemia or by lowering hyperglycemic glucose levels by insulin administration to streptozotocin-treated mice. 

Phrase: "Hyperglycemia in the presence of normal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "or"

Phrase: "deficient insulin levels"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "large increases in the phosphorylation levels of Akt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "GSK3 in the brain,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as"

Phrase: "did"

Phrase: "acute insulin administration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0199782:insulin administration [Therapeutic or Preventive Procedure]
   827   C0001554:Administration [Occupational Activity]
   827   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "whereas"

Phrase: "they"

Phrase: "were"

Phrase: "reduced by fasting-induced hypoglycemia"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C1428046:fasting induced [Gene or Genome]
   797   C0271708:Fasting Hypoglycemia [Disease or Syndrome]
   760   C0015663:Fasting [Finding]
   760   C0020615:Hypoglycaemia [Disease or Syndrome]
   760   C0205263:Induced [Functional Concept]
   760   C0392756:Reduced [Qualitative Concept]
   760   C1550565:fasting [Intellectual Product]
   726 E C0456962:Fast [Qualitative Concept]

Phrase: "or by lowering hyperglycemic glucose levels"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   790   C0428548:glucose levels [Laboratory or Test Result]
   756 E C0337438:glucose level [Laboratory Procedure]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C0441994:lowering [Spatial Concept]
   753   C2003888:Lowering [Activity]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C1548802:Lower [Body Location or Region]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "by insulin administration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0199782:insulin administration [Therapeutic or Preventive Procedure]
   861   C0001554:Administration [Occupational Activity]
   861   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "to streptozotocin-treated mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.148: Taken together, these results show that glucose as well as insulin contributes to the in vivo regulation of the phosphorylation of Akt and GSK3 in two regions of mouse brain, indicating that a glucose-sensing mechanism regulates brain Akt and GSK3. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "as well as"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "contributes to the in vivo regulation of the phosphorylation of Akt"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   772   C1158897:regulation of phosphorylation [Cell Function]
   756   C1515655:In Vivo [Spatial Concept]
           vivo
   738   C0031715:Phosphorylation [Molecular Function]
   738   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0812228:AKT [Gene or Genome]
   738   C0851285:Regulation [Governmental or Regulatory Activity]
   738   C1158886:Phosphorylation [Molecular Function]
   738   C1327622:Regulation [Biologic Function]
   738   C1880177:Contribute [Activity]

Phrase: "and"

Phrase: "GSK3 in two regions of mouse brain,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "indicating"

Phrase: "that"

Phrase: "a glucose-sensing mechanism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]
   734   C1658150:glucose sensing [Cell Function]

Phrase: "regulates"

Phrase: "brain Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.149: The present results extend previous studies of the effects of diabetes-related conditions on the phosphorylation of Akt or GSK3 in mouse brain. 

Phrase: "The present results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "previous studies of the effects of diabetes-related conditions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   742   C0947630:studies [Laboratory Procedure]
   728   C2985574:Study Condition [Qualitative Concept]
   708 E C0557651:Study [Manufactured Object]
   708 E C2603343:Study [Research Activity]

Phrase: "on the phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "or"

Phrase: "GSK3 in mouse brain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.150: The IRS-2-deficient mouse model of diabetes previously was found to have increased brain levels of phospho-Ser9-GSK3 (23), and a prior study had reported that these mice are hyperglycemic (24). 

Phrase: "The IRS-2-deficient mouse model of diabetes previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C2986594:Mouse Model [Experimental Model of Disease]
   742   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "increased brain levels of phospho-Ser9-GSK3"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   741   C0456949:Level 3 [Intellectual Product]
   739   C0006104:Brain [Body Part, Organ, or Organ Component]
   739   C0441889:Levels [Qualitative Concept]
   739   C1269537:Brain [Body Part, Organ, or Organ Component]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a prior study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "had"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "these mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "hyperglycemic"

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.151: Although the link was not noted previously, these results are consistent with our conclusion that with deficient insulin signaling, the phosphorylation levels of Akt and GSK3 in the brain can increase in response to elevated blood glucose levels. 

Phrase: "Although"

Phrase: "the link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "previously,"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with our conclusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that with deficient insulin signaling,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0011155:Deficient [Functional Concept]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0037083:Signaling [Cell Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1636779:% deficient [Quantitative Concept]
   760   C3537152:signaling [Biologic Function]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "the phosphorylation levels of Akt"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "GSK3 in the brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "can"

Phrase: "increase in response"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   790   C0442805:Increase [Functional Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]
   734 E C1517378:Gain [Quantitative Concept]
   706 E C0205217:Increased [Quantitative Concept]
   706 E C0439661:Acquired [Temporal Concept]
   706 E C0442808:Increasing [Functional Concept]
   706 E C1301820:Obtain [Functional Concept]
   706 E C1706701:Acquire [Activity]
   706 E C3245488:acquired [Intellectual Product]

Phrase: "to elevated blood glucose levels."
Meta Candidates (Total=21; Excluded=11; Pruned=0; Remaining=10)
   983   C0495706:Elevated blood glucose level [Finding]
   923   C0428554:blood glucose levels [Laboratory or Test Result]
   923   C0595877:elevated blood glucose [Finding]
   861   C0005802:Blood Glucose [Carbohydrate]
   861   C0428548:glucose levels [Laboratory or Test Result]
   827 E C0337438:glucose level [Laboratory Procedure]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0229664:Blood [Body Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.152: Other studies showed that in the absence of elevated glucose levels, deficient insulin signaling causes decreased phosphorylation of Akt and GSK3 in mouse brain. 

Phrase: "Other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that in the absence of elevated glucose levels,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   770   C0428548:glucose levels [Laboratory or Test Result]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0205250:Elevated [Qualitative Concept]
   744   C0332197:absence [Quantitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C1689985:Absence [Anatomical Abnormality]
   744   C3163633:Elevated [Qualitative Concept]
   737 E C0337438:glucose level [Laboratory Procedure]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "deficient insulin signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "decreased phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "GSK3 in mouse brain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.153: Neuron-specific insulin receptor knock-out (NIRKO) mice with unaltered cerebral glucose metabolism had 5060% decreases in the phosphorylation of Akt and GSK3 in brain, demonstrating that insulin receptor-linked signaling can influence the phosphorylation levels of these two kinases in the brain (25). 

Phrase: "Neuron-specific insulin receptor knock-out (NIRKO) mice with unaltered cerebral glucose metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0206745:Knock-out Mice [Mammal]
   736   C0025914:Mice [Mammal]
   736   C0025929:mice [Mammal]
   736   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "5060% decreases in the phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0547047:decreases [Quantitative Concept]
   714 E C0392756:Decrease [Qualitative Concept]

Phrase: "and"

Phrase: "GSK3 in brain,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "demonstrating"

Phrase: "that insulin receptor-linked signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1514762:Receptor Signaling [Molecular Function]
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]

Phrase: "can"

Phrase: "influence"

Phrase: "the phosphorylation levels of these two kinases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.154: This relationship also was observed in mice with diet-induced insulin resistance in which there was decreased phosphorylation of Akt and GSK3 in the brain while blood glucose concentrations remained normal (26). 

Phrase: "This relationship also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439849:Relationship [Qualitative Concept]
   861   C1705630:Relationship [Idea or Concept]
   861   C1706279:Relationship [Idea or Concept]
   861   C3540605:Relationship [Intellectual Product]

Phrase: "was"

Phrase: "observed in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C1441672:Observed [Functional Concept]

Phrase: "with diet-induced insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   861   C0021655:Insulin Resistance [Pathologic Function]
   861   C2700570:INSULIN RESISTANCE [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0237834:Resistance [Mental Process]
   812   C1514892:Resistance [Physiologic Function]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   741 E C0332325:Resistant [Functional Concept]
   741 E C1550464:resistent [Idea or Concept]
   741 E C2827757:RESISTANT [Laboratory or Test Result]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in which there"

Phrase: "was"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "GSK3 in the brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "while"

Phrase: "blood glucose concentrations"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   983   C2585282:Blood glucose concentration [Finding]
   913   C0427728:blood concentrations [Laboratory or Test Result]
   913   C0699870:blood concentrations [Quantitative Concept]
   913   C1313904:blood concentrations [Laboratory Procedure]
   884   C0427743:Glucose concentration [Laboratory Procedure]
   884   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0005802:Blood Glucose [Carbohydrate]

Phrase: "remained"

Phrase: "normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.155: Planel et al. 

Phrase: "Planel et al."
Processing 00000000.tx.156: (21) reported that 2.5 h after administration of a large dose of insulin (300 international units/kg) the level of phospho-Ser9-GSK3 increased in mouse brain. 

Phrase: "(21"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that 2.5 h after administration of a large dose of insulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   751   C0011744:h 2 [Element, Ion, or Isotope]
   736   C0033727:H+ [Element, Ion, or Isotope]
   736   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   736   C0441932:H+ [Classification]
   736   C0564385:/h [Quantitative Concept]

Phrase: "(300 international units/kg)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C1300561:unit/kg [Quantitative Concept]
   812   C0022718:KG [Geographic Area]
   812   C0439209:kg [Quantitative Concept]

Phrase: "the level of phospho-Ser9-GSK3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0456949:Level 3 [Intellectual Product]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "increased in mouse brain."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1521713:Mouse Brain [Tissue]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.157: Taken together with our results, these findings indicate that insulin has a significant influence on the phosphorylation levels of Akt and GSK3 in the brain, which decrease with deficient insulin signaling if glucose levels remain normal. 

Phrase: "Taken together with our results,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C1883357:Together [Qualitative Concept]
   760   C1883727:Taken [Conceptual Entity]
   726   C1274040:Result [Functional Concept]
   726 E C1515187:Take [Health Care Activity]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "a significant influence on the phosphorylation levels of Akt"

Phrase: "and"

Phrase: "GSK3 in the brain,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which"

Phrase: "decrease with deficient insulin"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0011155:Deficient [Functional Concept]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1636779:% deficient [Quantitative Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "if"

Phrase: "glucose levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0428548:glucose levels [Laboratory or Test Result]
   966 E C0337438:glucose level [Laboratory Procedure]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "remain"

Phrase: "normal."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.158: However, if hyperglycemia is associated with insulin deficiency, the elevated glucose levels cause large increases in the phosphorylation levels of brain Akt and GSK3. 

Phrase: "However,"

Phrase: "if"

Phrase: "hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "is"

Phrase: "associated with insulin deficiency,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0011155:Deficiency [Functional Concept]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0162429:Deficiency [Disease or Syndrome]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1623416:deficiency [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "the elevated glucose levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "large increases in the phosphorylation levels of brain Akt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "GSK3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.159: Thus, both insulin and glucose contribute to regulating the phosphorylation levels of these kinases in the brain, indicating that a glucose-sensing mechanism operates in conjunction with insulin signaling to regulate the phosphorylation of brain Akt and GSK3. 

Phrase: "Thus,"

Phrase: "both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulating"

Phrase: "the phosphorylation levels of these kinases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "indicating"

Phrase: "that"

Phrase: "a glucose-sensing mechanism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]
   734   C1658150:glucose sensing [Cell Function]

Phrase: "operates in conjunction with insulin signaling to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0037083:Signaling [Cell Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C2699427:Conjunction [Idea or Concept]
   748   C3242339:operate [Functional Concept]
   748   C3537152:signaling [Biologic Function]

Phrase: "regulate"

Phrase: "the phosphorylation of brain Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "GSK3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.160: View larger version (35K): [in this window] [in a new window]  FIGURE 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 7."
Processing 00000000.tx.161: Mouse brain Akt and GSK3 are highly phosphorylated 4 weeks after streptozotocin treatment. 

Phrase: "Mouse brain Akt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]
   734   C1521713:Mouse Brain [Tissue]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "phosphorylated"

Phrase: "4 weeks after streptozotocin treatment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1442465:4 Weeks [Temporal Concept]
   760   C0439230:weeks [Temporal Concept]
   726 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.162: Mice were treated with streptozotocin, and after 4 weeks, protein extracts from the cerebral cortex and hippocampus were immunoblotted for Phospho-Thr308-Akt, Phospho-Ser473-Akt, Total Akt (A) and Phospho-Ser21-GSK3, Phospho-Ser9-GSK3, Phospho-Tyr279/216-GSK3/, and Total GSK3/ (B). 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "treated with streptozotocin,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "and after 4 weeks,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0439230:weeks [Temporal Concept]
   770   C1515981:And [Idea or Concept]
   737 E C0332174:/week [Temporal Concept]

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extracts from the cerebral cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]
   760   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "immunoblotted for Phospho-Thr308-Akt,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0812228:AKT [Gene or Genome]
   726   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "Phospho-Ser473-Akt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "Total Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "(A"

Phrase: ")"

Phrase: "and"

Phrase: "Phospho-Ser21-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Phospho-Ser9-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Phospho-Tyr279/216-GSK3/,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   877   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   845   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Total GSK3/"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.163: C, control; 

Phrase: "C,"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.164: S, streptozotocin-treated. 

Phrase: "S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "streptozotocin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "treated."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.165: Quantitative values were obtained by densitometric measurements of immunoblots and are means  S.E. from five mice per group. 

Phrase: "Quantitative values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "obtained by densitometric measurements of immunoblots"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0242485:measurements [Functional Concept]
   753   C1301820:Obtained [Functional Concept]
   719   C0020985:Immunoblot [Laboratory Procedure]
   719 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "are"

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from five mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "per group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.166: *, p < 0.05 compared with control values.  

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with control values."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0042295:Values [Qualitative Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.167: The glucose-sensing regulation of brain Akt and GSK3 differentiates the responses of these enzymes in the brain from changes in peripheral tissues under insulin-resistant conditions. 

Phrase: "The glucose-sensing regulation of brain Akt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   835   C3270623:regulation of glucose sensing [Physiologic Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "differentiates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205615:differentiate [Qualitative Concept]

Phrase: "the responses of these enzymes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "from changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "in peripheral tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "under insulin-resistant conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.168: In our study, Akt and GSK3 in epididymal fat were dephosphorylated following streptozotocin treatment while the phosphorylation levels of Akt and GSK3 in the brain were dramatically increased in the same animals. 

Phrase: "In our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3 in epididymal fat"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "dephosphorylated"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "streptozotocin treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "while"

Phrase: "the phosphorylation levels of Akt"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "GSK3 in the brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "dramatically"

Phrase: "increased in the same animals."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0003062:Animals [Animal]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0445247:Same [Qualitative Concept]
Processing 00000000.tx.169: There have been only a limited number of studies of the in vivo phosphorylation states of Akt and GSK3 in peripheral tissues in insulin-resistant animal models, but these previous studies have reported results consistent with decreased or unchanged phosphorylation of GSK3 and/or Akt in contrast to the large increases in brain-phosphorylated Akt and GSK3. 

Phrase: "There"

Phrase: "have"

Phrase: "been"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a limited number of studies of the in vivo phosphorylation states of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0237753:*Number [Quantitative Concept]
   735   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "GSK3 in peripheral tissues"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in insulin-resistant animal models,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0599779:Models, Animal [Animal]
   812   C0003062:Animal [Animal]
   812   C3161035:Models [Intellectual Product]

Phrase: "but"

Phrase: "these previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "consistent with decreased"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "or"

Phrase: "unchanged phosphorylation of GSK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "and/or"

Phrase: "Akt in contrast to the large increases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0812228:AKT [Gene or Genome]

Phrase: "in brain-phosphorylated Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.170: In epididymal fat of mice with high fat diet-induced diabetes, the activity of GSK3 was increased 2-fold, likely indicative of decreased phosphorylation, whereas the activity of Akt was not changed (27). 

Phrase: "In epididymal fat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0424612:FAT [Organism Attribute]

Phrase: "of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "with high fat diet-induced diabetes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   717   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]

Phrase: "the activity of GSK3"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   879   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   840   C2261482:glycogen synthase kinase activity [Molecular Function]
   804   C1152133:glycogen synthase activity [Molecular Function]
   774   C1150423:kinase activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "2-fold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "likely indicative of decreased phosphorylation,"

Phrase: "whereas"

Phrase: "the activity of Akt"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.171: In these same mice there was a small decrease of GSK3 activity in liver and no change in skeletal muscle, demonstrating that regulation differs among tissues even in the periphery. 

Phrase: "In these same mice there"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "a small decrease of GSK3 activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392756:Decrease [Qualitative Concept]
   742   C0547047:Decrease [Quantitative Concept]

Phrase: "in liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "no change in skeletal muscle,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0442739:No change [Finding]
   806   C1548568:No change [Intellectual Product]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "demonstrating"

Phrase: "that regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "differs among tissues even"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0040300:Tissues [Tissue]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "in the periphery."
Processing 00000000.tx.172: Studies of streptozotocin-treated rats and Zucker diabetic fatty (ZDF) rats also reported no differences in skeletal muscle GSK3 activity (28, 29). 

Phrase: "Studies of streptozotocin-treated rats"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "Zucker diabetic fatty (ZDF) rats also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0034719:Rats, Zucker [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "no differences in skeletal muscle GSK3 activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   706   C1705241:*Difference [Quantitative Concept]
   706   C1705242:Difference [Qualitative Concept]

Phrase: "(28,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.173: However, in human patients with type 2 diabetes, the GSK3 activity was elevated 2-fold in skeletal muscle, consistent with a decrease in the inhibitory serine phosphorylation of GSK3 (30). 

Phrase: "However,"

Phrase: "in human patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "the GSK3 activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   933   C2261482:glycogen synthase kinase activity [Molecular Function]
   911   C1152133:glycogen synthase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "2-fold in skeletal muscle,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332462:Fold [Spatial Concept]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "consistent with a decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in the inhibitory serine phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "of GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.174: The myocardium of streptozotocin-treated rats displayed decreased basal phosphorylation of Akt on Thr308, but not on Ser473, and decreased insulin-induced serine phosphorylation of both GSK3 isoforms (31). 

Phrase: "The myocardium of streptozotocin-treated rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027061:Myocardium [Tissue]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "decreased basal phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "on Thr308,"

Phrase: "but"

Phrase: "not on Ser473,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1518422:Not [Functional Concept]

Phrase: "and"

Phrase: "decreased insulin-induced serine phosphorylation of both GSK3 isoforms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0031715:Phosphorylation [Molecular Function]
   736   C1158886:Phosphorylation [Molecular Function]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.175: Overall, these studies indicate that the effects of insulin resistance on Akt and GSK3 vary considerably among different tissues and that changes in the brain are relatively large, as well as opposite to, changes in peripheral tissues. 

Phrase: "Overall,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "these studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "that"

Phrase: "the effects of insulin resistance"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "vary"

Phrase: "considerably among different tissues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040300:Tissues [Tissue]
   770   C1705242:Different [Qualitative Concept]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "that changes in the brain"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "relatively large,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0549177:Large [Quantitative Concept]

Phrase: "as well as"

Phrase: "opposite to,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1521805:Opposite [Spatial Concept]

Phrase: "changes in peripheral tissues."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0040300:Tissues [Tissue]
   770   C0205100:Peripheral [Spatial Concept]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]
   737 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.176: During the last few years increasing attention has been focused on GSK3 as a potential therapeutic target in diabetes because inhibition of GSK3 facilitates control of glucose levels in animal models of insulin resistance (32). 

Phrase: "During the last few years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "attention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004268:Attention [Mental Process]

Phrase: "has"

Phrase: "been"

Phrase: "focused on GSK3"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205234:Focused [Spatial Concept]
   753   C1285542:focused [Functional Concept]

Phrase: "as a potential therapeutic target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521840:Target [Functional Concept]
   827   C2986546:TARGET [Diagnostic Procedure]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "because"

Phrase: "inhibition of GSK3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "facilitates"

Phrase: "control of glucose levels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0726398:GLUCOSE CONTROL [Indicator, Reagent, or Diagnostic Aid]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "in animal models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599779:Models, Animal [Animal]
   861   C0003062:Animal [Animal]
   861   C3161035:Models [Intellectual Product]

Phrase: "of insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.177: Although as noted above there is limited data indicating that GSK3 in peripheral tissues is abnormally activated in diabetes, this is not a requirement for inhibitors to contribute to the control of glucose levels. 

Phrase: "Although"

Phrase: "as"

Phrase: "noted above there"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1316572:Note [Clinical Attribute]
   756   C1317574:Note [Intellectual Product]
   756   C1369612:Note [Clinical Attribute]

Phrase: "is"

Phrase: "limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicating"

Phrase: "that GSK3 in peripheral tissues"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "abnormally"

Phrase: "activated in diabetes,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "this"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a requirement for inhibitors to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514873:Requirement [Functional Concept]

Phrase: "contribute to the control of glucose levels."
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   778   C0428548:glucose levels [Laboratory or Test Result]
   774   C0726398:GLUCOSE CONTROL [Indicator, Reagent, or Diagnostic Aid]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0243148:control [Qualitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1880177:Contribute [Activity]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   745 E C0337438:glucose level [Laboratory Procedure]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.178: However, overexpression of GSK3 in skeletal muscle was recently found to be sufficient to cause glucose intolerance (33). 

Phrase: "However,"

Phrase: "overexpression of GSK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1514559:Overexpression [Genetic Function]
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "glucose intolerance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0271650:Glucose Intolerance [Disease or Syndrome]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0231199:Intolerance [Organism Function]
   861   C1744706:intolerance [Intellectual Product]
   861   C2355652:Intolerance [Organism Attribute]
   789 E C0231200:Intolerant [Functional Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.179: Administration of a peptide inhibitor of GSK3, L803-mts, increased glucose tolerance in diabetic mice (34). 

Phrase: "Administration of a peptide inhibitor of GSK3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0001554:Administration [Occupational Activity]
   739   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "L803-mts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1700727:L803-mts [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increased glucose tolerance in diabetic mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0178665:Glucose tolerance [Physiologic Function]
   790   C0860803:increased glucose [Finding]
   783   C0151956:Increased tolerance [Finding]
   753   C0013220:Tolerance [Finding]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0020963:Tolerance [Pathologic Function]
   753   C0220929:tolerance [Mental Process]
   753   C0231197:Tolerance [Physiologic Function]
   753   C1704410:Tolerance [Qualitative Concept]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.180: Also, administration of rosiglitazone, a peroxisome proliferator-activated receptor agonist that also inhibits GSK3, reduced circulating blood glucose levels in ZDF rats and in patients with type 2 diabetes (35, 36). 

Phrase: "Also,"

Phrase: "administration of rosiglitazone,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001554:Administration [Occupational Activity]
   790   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "a peroxisome proliferator-activated receptor agonist"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C2987634:Agonist [Pharmacologic Substance]
   771   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   771   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]

Phrase: "that also"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "reduced circulating blood glucose levels in ZDF rats"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   782   C0428554:blood glucose levels [Laboratory or Test Result]
   760   C0005802:Blood Glucose [Carbohydrate]
   760   C0428548:glucose levels [Laboratory or Test Result]
   760   C0440738:Circulating blood [Body Substance]
   739   C0005767:Blood [Tissue]
   739   C0005768:blood [Body Substance]
   739   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   739   C0229664:Blood [Body Substance]
   739   C0441889:Levels [Qualitative Concept]
   726 E C0337438:glucose level [Laboratory Procedure]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "and in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1515981:And [Idea or Concept]

Phrase: "with type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(35,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.181: Ring et al. 

Phrase: "Ring et al."
Processing 00000000.tx.182: (37) found that in several models of diabetes, ob/ob mice, db/db mice, and ZDF rats, two GSK3 inhibitors, CHIR98014 and CHIR99021, lowered plasma glucose levels by as much as 50% in a dose-dependent manner without changing insulin concentrations. 

Phrase: "(37"

Phrase: ")"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that in several models of diabetes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C3161035:Models [Intellectual Product]

Phrase: "ob/ob mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "db/db mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "ZDF rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "two GSK3 inhibitors,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   839   C1152564:Kinase Inhibitors [Molecular Function]
   822 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   822 E C3537023:kinase inhibitor [Molecular Function]
   822 E C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   799   C0243077:inhibitors [Chemical Viewed Functionally]
   766 E C1999216:Inhibitor [Qualitative Concept]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "CHIR98014"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1176213:Chir98014 [Organic Chemical]

Phrase: "and"

Phrase: "CHIR99021,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1176214:Chir99021 [Organic Chemical]

Phrase: "lowered plasma glucose levels by"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   844   C0455280:glucose levels plasma [Laboratory or Test Result]
           plasma glucose
   806   C0202042:Plasma glucose [Laboratory Procedure]
   806   C0428548:glucose levels [Laboratory or Test Result]
   773 E C0337438:glucose level [Laboratory Procedure]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0032105:Plasma [Body Substance]
   760   C0441889:Levels [Qualitative Concept]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "as"

Phrase: "much as 50%"

Phrase: "in a dose-dependent manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "without changing insulin concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.183: Two reports also showed that the GSK3 inhibitor CHIR98023 lowered glucose concentrations in ZDF rats during a glucose tolerance test (29, 38). 

Phrase: "Two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "also"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the GSK3 inhibitor CHIR98023"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1171714:CHIR98023 [Organic Chemical]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "lowered"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0441994:lowered [Spatial Concept]
  1000   C1272755:Lowered [Quantitative Concept]
  1000   C2003888:Lowered [Activity]
   966 E C1548802:Lower [Body Location or Region]

Phrase: "glucose concentrations in ZDF rats"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   774   C0427743:concentrations glucose [Laboratory Procedure]
   774   C1287281:concentrations glucose [Laboratory or Test Result]
   748   C0086045:Concentrations [Mental Process]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "during a glucose tolerance test"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0017741:Glucose tolerance test [Diagnostic Procedure]
   913   C0337438:glucose test [Laboratory Procedure]
   913   C0595310:GLUCOSE TEST [Medical Device]
   901   C0178665:Glucose tolerance [Physiologic Function]
   901   C0201777:Tolerance test [Laboratory Procedure]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0220929:tolerance [Mental Process]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0392366:test [Intellectual Product]
   827   C1704410:Tolerance [Qualitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]

Phrase: "(29,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.184: These results indicate that inhibition of GSK3 in the periphery improves glucose regulation in diabetic animals. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that inhibition of GSK3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "in the periphery"

Phrase: "improves"

Phrase: "glucose regulation in diabetic animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.185: However, our finding of increased serine-phosphorylated GSK3 in the brain of streptozotocin-treated mice, which was reflected in reduced GSK3 activity, raises the question of whether further inhibition of brain GSK3 by the administration of GSK3 inhibitors might be detrimental to brain function. 

Phrase: "However,"

Phrase: "our finding of increased serine-phosphorylated GSK3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0037088:Finding [Sign or Symptom]
   739   C0243095:Finding [Finding]
   739   C2825141:Finding [Finding]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of streptozotocin-treated mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "which"

Phrase: "was"

Phrase: "reflected in reduced GSK3 activity,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   869   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   833   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   822   C2261482:glycogen synthase kinase activity [Molecular Function]
   800   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C1152133:glycogen synthase activity [Molecular Function]
   770   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0086439:Reduced Activity [Sign or Symptom]
   767   C1150423:kinase activity [Molecular Function]
   744   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205177:Activity [Functional Concept]
   744   C0392756:Reduced [Qualitative Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0558058:reflected [Mental Process]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "raises"

Phrase: "the question of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1522634:Question [Intellectual Product]

Phrase: "whether"

Phrase: "further inhibition of brain GSK3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "by the administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001554:Administration [Occupational Activity]
  1000   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "of GSK3 inhibitors"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C1152564:Kinase Inhibitors [Molecular Function]
   836 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   836 E C3537023:kinase inhibitor [Molecular Function]
   836 E C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0243077:inhibitors [Chemical Viewed Functionally]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   771 E C1999216:Inhibitor [Qualitative Concept]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "might"

Phrase: "be"

Phrase: "detrimental to brain function."
Processing 00000000.tx.186: Thus, it may be preferable to consider GSK3 inhibitors with limited ability to penetrate the blood brain barrier to limit GSK3 inhibitory effects to the periphery for the possible treatment of diabetes. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "preferable to"

Phrase: "consider"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:consider [Idea or Concept]

Phrase: "GSK3 inhibitors with limited ability to"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   762   C1152564:Kinase Inhibitors [Molecular Function]
   762   C3537035:inhibitors kinase [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   745 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   745 E C3537023:kinase inhibitor [Molecular Function]
   742   C0243077:inhibitors [Chemical Viewed Functionally]
   708 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "penetrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205321:penetrate [Functional Concept]

Phrase: "the blood brain barrier to"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   923   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
   923   C1305865:Blood-brain barrier [Organ or Tissue Function]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C0229664:Blood [Body Substance]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1706912:BARRIER [Medical Device]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "limit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "GSK3 inhibitory effects to the periphery"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "for the possible treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "of diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.187: View larger version (39K): [in this window] [in a new window]  FIGURE 8. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(39K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 8."
Processing 00000000.tx.188: Akt and GSK3 are highly phosphorylated in db/db mouse brain. 

Phrase: "Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "phosphorylated in db/db mouse brain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1521713:Mouse Brain [Tissue]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.189: Protein extracts from the cerebral cortex and hippocampus were immunoblotted in 8-week-old db/db mice for Phospho-Thr308-Akt, Phospho-Ser473-Akt, and Total Akt (A), and Phospho-Ser21-GSK3, Phospho-Ser9-GSK3, Phospho-Tyr279/216-GSK3/, and Total GSK3/ (B). 

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extracts from the cerebral cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]
   760   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "immunoblotted in 8-week-old db/db mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0332174:/week [Temporal Concept]
   744   C0439230:week [Temporal Concept]
   744   C0580836:Old [Temporal Concept]
   711   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "for Phospho-Thr308-Akt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "Phospho-Ser473-Akt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "Total Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Phospho-Ser21-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Phospho-Ser9-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Phospho-Tyr279/216-GSK3/,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   877   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   845   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Total GSK3/"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.190: Quantitative values were obtained by densitometric measurements of immunoblots and are means  S.E. from three mice per group. 

Phrase: "Quantitative values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "obtained by densitometric measurements of immunoblots"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0242485:measurements [Functional Concept]
   753   C1301820:Obtained [Functional Concept]
   719   C0020985:Immunoblot [Laboratory Procedure]
   719 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "are"

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from three mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "per group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.191: *, p < 0.05 compared with control values.  

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with control values."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0042295:Values [Qualitative Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.192: View larger version (28K): [in this window] [in a new window]  FIGURE 9. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 9."
Processing 00000000.tx.193: Increased brain Akt and GSK3 phosphorylation in streptozotocin-treated mice is reversed by insulin administration. 

Phrase: "Increased brain Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK3 phosphorylation in streptozotocin-treated mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "reversed by insulin administration."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0199782:insulin administration [Therapeutic or Preventive Procedure]
   770   C0001554:Administration [Occupational Activity]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533734:Administration [Therapeutic or Preventive Procedure]
   770   C1579433:Insulin [Pharmacologic Substance]
   737   C1555029:Reverse [Idea or Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.194: Mice were treated with streptozotocin and after 3 days, food was withdrawn overnight. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "treated with streptozotocin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "and after 3 days,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0439228:days [Temporal Concept]
   770   C1515981:And [Idea or Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "food"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "was"

Phrase: "withdrawn"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0424092:Withdrawn [Finding]
  1000   C2349954:Withdrawn [Activity]
  1000   C2825032:Withdrawn [Mental or Behavioral Dysfunction]

Phrase: "overnight."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.195: After an ip injection of 5 international units/kg of insulin, blood glucose and serum insulin concentrations were measured (A). 

Phrase: "After an ip injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "of 5 international units/kg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C1300561:unit/kg [Quantitative Concept]
   812   C0022718:KG [Geographic Area]
   812   C0439209:kg [Quantitative Concept]

Phrase: "of insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "serum insulin concentrations"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   896   C0683149:serum concentration [Quantitative Concept]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0428357:Serum insulin [Laboratory Procedure]
   734   C1261415:serum insulin [Laboratory or Test Result]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.196: Insulin values were divided by ten to show the changes in insulin and glucose levels on the same graph. 

Phrase: "Insulin values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "divided by ten to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0014518:TEN [Disease or Syndrome]
   770   C0205456:Ten [Quantitative Concept]
   770   C0332849:Divided [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the changes in insulin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   816   C0025320:The change [Physiologic Function]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "glucose levels on the same graph."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0428548:glucose levels [Laboratory or Test Result]
   756 E C0337438:glucose level [Laboratory Procedure]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.197: Protein extracts from the cerebral cortex and hippocampus were immunoblotted for Phospho-Thr308-Akt, Phospho-Ser473-Akt, and Total Akt (B), and Phospho-Ser21-GSK3, Phospho-Ser9-GSK3, Phospho-Tyr279/216-GSK3/, and Total GSK3/ (C). 

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extracts from the cerebral cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]
   760   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "immunoblotted for Phospho-Thr308-Akt,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0812228:AKT [Gene or Genome]
   726   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "Phospho-Ser473-Akt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "Total Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Phospho-Ser21-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Phospho-Ser9-GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Phospho-Tyr279/216-GSK3/,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   877   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   845   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Total GSK3/"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.198: Quantitative values were obtained by densitometric measurements of immunoblots and are means  S.E. from three mice per group.  

Phrase: "Quantitative values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "obtained by densitometric measurements of immunoblots"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0242485:measurements [Functional Concept]
   753   C1301820:Obtained [Functional Concept]
   719   C0020985:Immunoblot [Laboratory Procedure]
   719 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "are"

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from three mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "per group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.199: Considering the central roles of Akt and GSK3 in many cellular processes, and the critical role that glucose plays in neuronal function, one goal of this investigation was to test if changes in circulating levels of glucose affected the regulatory phosphorylation states of these kinases. 

Phrase: "Considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "the central roles of Akt"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "GSK3 in many cellular processes,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "the critical role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "that glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "plays in neuronal function,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0031843:function [Physiologic Function]
   770   C0032214:Play [Daily or Recreational Activity]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C0542341:Function [Functional Concept]
   770   C0600138:Plays [Finding]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "one goal of this investigation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0018017:Goal [Intellectual Product]
   760   C1571704:Goal [Idea or Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "if"

Phrase: "changes in circulating levels of glucose"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the regulatory phosphorylation states of these kinases."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]
   748   C1301808:states [Geographic Area]
   714 E C1442792:State [Functional Concept]
   714 E C3148680:State [Geographic Area]
Processing 00000000.tx.200: The coupling of these kinases is an interesting, somewhat novel, signaling pathway because phosphorylation increases Akt activity but decreases GSK3 activity, so the signal strength has opposite effects on the two kinases (39). 

Phrase: "The coupling of these kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1948027:Coupling [Functional Concept]

Phrase: "is"

Phrase: "an interesting, somewhat novel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205314:Novel [Temporal Concept]
   827   C0679622:novel [Intellectual Product]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "because"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "Akt activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "but"

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "GSK3 activity,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   933   C2261482:glycogen synthase kinase activity [Molecular Function]
   911   C1152133:glycogen synthase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "so"

Phrase: "the signal strength"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0237897:Strength [Quantitative Concept]
   861   C0808080:Strength [Idea or Concept]
   861   C1705922:Strength [Qualitative Concept]
   789 E C0442821:Strong [Qualitative Concept]

Phrase: "has"

Phrase: "opposite effects on the two kinases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.201: When cells are adequately stimulated the activation-inducing phosphorylation of Akt is enhanced, as is the consequential Akt-induced inhibitory serine phosphorylation of GSK3. 

Phrase: "When"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "adequately"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "the activation-inducing phosphorylation of Akt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C2248185:activation of phosphorylation [Cell Function]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: ","

Phrase: "as is"

Phrase: "the consequential Akt-induced inhibitory serine phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0031715:Phosphorylation [Molecular Function]
   799   C1158886:Phosphorylation [Molecular Function]

Phrase: "of GSK3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.202: Both physiological and pathological changes in circulating glucose levels were found to regulate the phosphorylation levels of Akt and GSK3 in mouse brain in vivo. 

Phrase: "Both physiological"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205463:Physiological [Functional Concept]
   928 E C0031842:Physiology [Biomedical Occupation or Discipline]
   928 E C0031843:physiology [Physiologic Function]

Phrase: "and"

Phrase: "pathological changes in circulating glucose levels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "the phosphorylation levels of Akt"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "GSK3 in mouse brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.203: Because these were altered by both fasting and acute glucose administration, it appears that the phosphorylation levels of Akt and GSK3 are perpetually fluctuating in response to food intake or deprivation. 

Phrase: "Because"

Phrase: "these"

Phrase: "were"

Phrase: "altered by both fasting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0015663:Fasting [Finding]
   770   C0392747:Altered [Functional Concept]
   770   C1550565:fasting [Intellectual Product]
   737 E C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "acute glucose administration,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001554:Administration [Occupational Activity]
   827   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that"

Phrase: "the phosphorylation levels of Akt"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "perpetually"

Phrase: "fluctuating in response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0231241:Fluctuating [Temporal Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to food intake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013470:Food Intake [Organism Function]
   861   C1512806:Intake [Functional Concept]

Phrase: "or"

Phrase: "deprivation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871712:Deprivation [Qualitative Concept]
Processing 00000000.tx.204: This is rather surprising considering previous notions that these enzymes are tightly controlled and primarily regulated by neurohormones such as growth factors (13, 14). 

Phrase: "This"

Phrase: "is"

Phrase: "rather"

Phrase: "surprising"

Phrase: "considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "previous notions"

Phrase: "that"

Phrase: "these enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "are"

Phrase: "tightly"

Phrase: "controlled"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C2587213:Controlled [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "primarily"

Phrase: "regulated by neurohormones"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0597049:Neurohormones [Hormone,Neuroreactive Substance or Biogenic Amine]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   756 E C1149491:neurohormone [Molecular Function]

Phrase: "such as growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.205: With pathological hyperglycemia, these fluctuations are eliminated and the enzymes are maintained in a persistent state of hyperphosphorylation. 

Phrase: "With pathological hyperglycemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "these fluctuations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0231239:fluctuations [Sign or Symptom]
   966 E C0231241:Fluctuation [Temporal Concept]
   966 E C2827773:Fluctuation% [Qualitative Concept]

Phrase: "are"

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "and"

Phrase: "the enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "are"

Phrase: "maintained in a persistent state of hyperphosphorylation."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0205322:Persistent [Temporal Concept]
   748   C1301808:State [Geographic Area]
   748   C1314677:Maintained [Functional Concept]
   748   C1442792:State [Functional Concept]
   748   C3148680:State [Geographic Area]
   714 E C0024501:Maintain [Activity]
Processing 00000000.tx.206: It is possible that loss of normal fluctuations of these two key kinases contributes to cognitive impairments that can occur in patients with diabetes, especially when glucose is poorly controlled or in elderly diabetic patients (4). 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that loss of normal fluctuations of these two key kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1517945:Loss [Quantitative Concept]

Phrase: "contributes to cognitive impairments"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0338656:cognitive impairments [Mental or Behavioral Dysfunction]
   770   C0684336:Impairments [Pathologic Function]
   770   C1516691:Cognitive [Functional Concept]
   770   C1880177:Contribute [Activity]
   770   C2598156:Impairments [Clinical Attribute]

Phrase: "that"

Phrase: "can"

Phrase: "occur in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "with diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "especially"

Phrase: "when"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "is"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "controlled"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C2587213:Controlled [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "or in elderly diabetic patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0001792:Elderly [Population Group]
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0241863:DIABETIC [Finding]
   760   C1999167:elderly [Population Group]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.207: Although only short term glucose deprivation was studied here, it may be relevant that a number of psychiatric disorders are linked with hypoglycemic states. 

Phrase: "Although"

Phrase: "only short term glucose deprivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0871712:Deprivation [Qualitative Concept]

Phrase: "was"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "here,"

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "relevant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347946:Relevant [Qualitative Concept]

Phrase: "that"

Phrase: "a number of psychiatric disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "are"

Phrase: "linked with hypoglycemic states."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0020616:Hypoglycaemic [Pharmacologic Substance]
   770   C1301808:states [Geographic Area]
   737 E C1442792:State [Functional Concept]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]
   737 E C3148680:State [Geographic Area]
Processing 00000000.tx.208: For example, depression is frequently associated with impaired appetite and weight loss, and anorexia nervosa represents a more severe hypoglycemic state of long duration. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "depression"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0011570:Depression [Mental or Behavioral Dysfunction]
  1000   C0011581:Depression [Mental or Behavioral Dysfunction]
  1000   C0344315:Depression [Finding]
  1000   C0349217:depression nos [Mental or Behavioral Dysfunction]
  1000   C0460137:Depression [Functional Concept]
   928 E C0549249:DEPRESSED [Finding]

Phrase: "is"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "associated with impaired appetite"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   819   C1971624:APPETITE IMPAIRED [Finding]
   770   C0003618:Appetite [Organism Function]
   770   C0221099:Impaired [Functional Concept]
   770   C0684336:Impaired [Pathologic Function]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "weight loss,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0043096:WEIGHTLOSS [Finding]
  1000   C2911645:Weight loss [Finding]
   861   C0005910:weight [Organism Attribute]
   861   C0043100:Weight [Quantitative Concept]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1517945:Loss [Quantitative Concept]
   861   C1705104:Weight [Idea or Concept]

Phrase: "and"

Phrase: "anorexia nervosa"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003125:Anorexia Nervosa [Mental or Behavioral Dysfunction]
   861   C0003123:Anorexia [Disease or Syndrome]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a more severe hypoglycemic state of long duration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1301808:State [Geographic Area]
   744   C1442792:State [Functional Concept]
   744   C3148680:State [Geographic Area]
Processing 00000000.tx.209: Hypoglycemia is associated with decreased serine phosphorylation of GSK3, which is correlated with increased enzymatic activity, so it is of interest that agents therapeutic for depressive mood disorders can increase GSK3 phosphorylation in mouse brain in vivo (40, 41). 

Phrase: "Hypoglycemia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0020615:Hypoglycaemia [Disease or Syndrome]
   928 E C0020616:Hypoglycaemic [Pharmacologic Substance]

Phrase: "is"

Phrase: "associated with decreased serine phosphorylation of GSK3,"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   806   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0332281:Associated with [Qualitative Concept]
           Associated
   757   C0072402:Serine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   757   C1291109:Decreased glycogen [Finding]
   739   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   739   C0031715:Phosphorylation [Molecular Function]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205216:Decreased [Quantitative Concept]
   739   C0392756:Decreased [Qualitative Concept]
   739   C0442797:decreased [Qualitative Concept]
   739   C1158886:Phosphorylation [Molecular Function]
   706 E C0547047:Decrease [Quantitative Concept]
   706 E C0750490:Associate [Idea or Concept]
   706 E C1706221:Associate [Professional or Occupational Group]

Phrase: "which"

Phrase: "is"

Phrase: "correlated with increased enzymatic activity,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C2267219:Enzymatic Activity [Molecular Function]
   797   C0474395:increased activity [Finding]
   760   C0205177:Activity [Functional Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0442805:Increased [Functional Concept]
   760   C1561536:*Activity [Idea or Concept]
   760   C1707520:Correlated [Qualitative Concept]

Phrase: "so"

Phrase: "it"

Phrase: "is of"

Phrase: "interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]

Phrase: "that agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0450442:Agent [Chemical Viewed Functionally]
   966   C1254351:Agent [Pharmacologic Substance]
   966   C1521826:Agent [Intellectual Product]

Phrase: "therapeutic for depressive mood disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   760   C0302350:Therapeutic [Functional Concept]

Phrase: "can"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "GSK3 phosphorylation in mouse brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.210: Thus, the phosphorylation of Akt and GSK3 is regulated by integrated signals derived from glucose as well as neurohormones such as insulin. 

Phrase: "Thus,"

Phrase: "the phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "regulated by integrated signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   737   C1710082:Signal [Phenomenon or Process]

Phrase: "derived from glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "as well as"

Phrase: "neurohormones such as insulin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0597049:Neurohormones [Hormone,Neuroreactive Substance or Biogenic Amine]
   737 E C1149491:neurohormone [Molecular Function]
Processing 00000000.tx.211: This allows the linked Akt-GSK3 signaling pathway to act as a cellular glucose sensor and integrator of multiple signals, responses that may contribute to neuronal dysfunction in diabetes and other disorders involving altered glucose availability.  

Phrase: "This"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "the linked Akt-GSK3 signaling pathway to"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   871   C1515844:AKT Signaling Pathway [Molecular Function]
   807   C0037083:signaling pathway [Cell Function]
   807   C0086982:Signaling Pathway [Molecular Function]
   791 E C0037080:Signal Pathway [Molecular Function]
   791   C1704259:Pathway [Molecular Function]
   791   C1705987:Pathway [Conceptual Entity]

Phrase: "act as a cellular glucose sensor"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0872382:GLUCOSE SENSOR [Medical Device]
   790   C1625163:glucose sensor [Molecular Function]
   753   C0007634:Cellular [Cell]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C0178539:Cellular [Functional Concept]
   753   C0183210:Sensor [Medical Device]
   753   C1705193:Sensor [Manufactured Object]

Phrase: "and"

Phrase: "integrator of multiple signals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0309311:INTEGRATOR [Amino Acid, Peptide, or Protein,Pharmacologic Substance,Vitamin]
   770   C1706057:Integrator [Medical Device]

Phrase: "responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0871261:responses [Organism Attribute]
   966 E C1704632:Response [Finding]
   966 E C1706817:Response [Intellectual Product]
   966 E C2911692:Response [Mental Process]

Phrase: "that"

Phrase: "may"

Phrase: "contribute to neuronal dysfunction"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0031847:dysfunction [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1880177:Contribute [Activity]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "other disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorders [Disease or Syndrome]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "altered glucose availability."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0470187:Availability [Functional Concept]
Processing 00000000.tx.212: FOOTNOTES  * This research was supported by National Institutes of Health Grants NS37768 and AG021045. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "was"

Phrase: "supported by National Institutes of Health Grants NS37768"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   744   C0018173:Grants [Quantitative Concept]
   744   C0018684:Health [Idea or Concept]
   744   C0021622:Institutes [Organization]
   744   C1521721:Supported [Conceptual Entity]
   744   C3245503:national [Intellectual Product]
   711 E C0183683:Support [Medical Device]
   711 E C1272753:Institute [Idea or Concept]
   711 E C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "AG021045."
Processing 00000000.tx.213: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.214: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.215: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.216: 1 To whom correspondence should be addressed: Dept. of Psychiatry, 1720 Seventh Ave. 

Phrase: "1 To whom correspondence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0282413:Correspondence [Intellectual Product]
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Psychiatry,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "1720 Seventh Ave."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0108844:AVE [Therapeutic or Preventive Procedure]
Processing 00000000.tx.217: S., SC1057, University of Alabama at Birmingham, Birmingham, AL 35294-0017. 

Phrase: "S."

Phrase: ","

Phrase: "SC1057,"

Phrase: "University of Alabama at Birmingham,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0001895:Alabama [Geographic Area]
   760   C0041740:University [Manufactured Object,Organization]
   760   C1551894:Alabama [Language]
   760   C2825084:Alabama [Eukaryote]

Phrase: "Birmingham,"

Phrase: "AL 35294-0017."
Processing 00000000.tx.218: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.219: 205-934-7023; 

Phrase: "205-934-7023"

Phrase: ";"
Processing 00000000.tx.220: Fax: 205-934-3709; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "205-934-3709"

Phrase: ";"
Processing 00000000.tx.221: E-mail: jope{at}uab.edu . 2 The abbreviations used are: GSK3, glycogen synthase kinase-3; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "jope{at}uab.edu . 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "glycogen synthase kinase-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.222: ip, intraperitoneally; 

Phrase: "ip,"

Phrase: "intraperitoneally"

Phrase: ";"
Processing 00000000.tx.223: ZDF, Zucker diabetic fatty; 

Phrase: "ZDF, Zucker diabetic fatty"

Phrase: ";"
Processing 00000000.tx.224: MOPS, 4-morpholinepropanesulfonic acid.  

Phrase: "MOPS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0066823:MOPS [Organic Chemical]
  1000   C1271466:Mops [Mammal]

Phrase: "4-morpholinepropanesulfonic acid."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.225: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Zimmet, P., Alberti, K. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Zimmet,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Alberti,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.226: G., and Shaw, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Shaw,"

Phrase: "J."
Processing 00000000.tx.227: (2001) Nature 414, 782787[CrossRef][Medline] [OrderarticleviaInfotrieve] Saltiel, A. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Nature 414,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "782787"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Saltiel,"

Phrase: "A."
Processing 00000000.tx.228: R., and Kahn, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Kahn,"

Phrase: "C."
Processing 00000000.tx.229: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.230: (2001) Nature 414, 799806[CrossRef][Medline] [OrderarticleviaInfotrieve] White, M. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Nature 414,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "799806"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.231: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.232: (2003) Science 302, 17101711[Abstract/Free FullText] Gispen, W. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Science 302,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "17101711"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gispen,"

Phrase: "W."
Processing 00000000.tx.233: H., and Biessels, G. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Biessels,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.234: J. 

Phrase: "J."
Processing 00000000.tx.235: (2000) Trends Neurosci. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.236: 23, 542549[CrossRef][Medline] [OrderarticleviaInfotrieve] Hofman, M. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "542549"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hofman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.237: A. 

Phrase: "A."
Processing 00000000.tx.238: (1983) Q. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Q."
Processing 00000000.tx.239: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.240: Biol. 

Phrase: "Biol."
Processing 00000000.tx.241: 58, 495512[CrossRef][Medline] [OrderarticleviaInfotrieve] McCall, A. 

Phrase: "58,"

Phrase: "495512"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] McCall,"

Phrase: "A."
Processing 00000000.tx.242: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.243: (2004) Eur. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.244: J. 

Phrase: "J."
Processing 00000000.tx.245: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.246: 490, 147158[CrossRef][Medline] [OrderarticleviaInfotrieve] Laughlin, S. 

Phrase: "490,"

Phrase: "147158"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Laughlin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.247: B., and Sejnowski, T. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Sejnowski,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.248: J. 

Phrase: "J."
Processing 00000000.tx.249: (2003) Science 301, 18701874[Abstract/Free FullText] McEwen, B. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Science 301,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "18701874"

Phrase: "[Abstract/Free FullText"

Phrase: "] McEwen,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.250: S., and Reagan, L. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Reagan,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.251: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.252: (2004) Eur. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.253: J. 

Phrase: "J."
Processing 00000000.tx.254: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.255: 490, 1324[CrossRef][Medline] [OrderarticleviaInfotrieve] Attwell, D., and Iadecola, C. 

Phrase: "490,"

Phrase: "1324"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Attwell,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Iadecola,"

Phrase: "C."
Processing 00000000.tx.256: (2002) Trends Neurosci. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.257: 25, 621625[CrossRef][Medline] [OrderarticleviaInfotrieve] Routh, V. 

Phrase: "25,"

Phrase: "621625"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Routh,"

Phrase: "V."
Processing 00000000.tx.258: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.259: (2002) Physiol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Physiol."
Processing 00000000.tx.260: Behav. 

Phrase: "Behav."
Processing 00000000.tx.261: 76, 403413[CrossRef][Medline] [OrderarticleviaInfotrieve] Kyriaki G (2003) Cell Mol. 

Phrase: "76,"

Phrase: "403413"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kyriaki G (2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "Cell Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0027960:Mole [Neoplastic Process]
   861   C0324740:Mole [Mammal]
   861   C0439189:Mole [Quantitative Concept]
   861   C1456781:mole [Neoplastic Process]
   861   C1824986:mol [Gene or Genome]
   777 E C0026367:Molar [Body Part, Organ, or Organ Component]
   761 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.262: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.263: 23, 125[CrossRef][Medline] [OrderarticleviaInfotrieve] Cross, D. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "125"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Cross,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828360:Cross [Conceptual Entity]

Phrase: "D."
Processing 00000000.tx.264: A., Alessi, D. 

Phrase: "A.,"

Phrase: "Alessi,"

Phrase: "D."
Processing 00000000.tx.265: R., Cohen, P., Andjelkovich, M., and Hemmings, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cohen,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Andjelkovich,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Hemmings,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.266: A. 

Phrase: "A."
Processing 00000000.tx.267: (1995) Nature 378, 785789[CrossRef][Medline] [OrderarticleviaInfotrieve] Lawlor, M. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nature 378,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "785789"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lawlor,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.268: A., and Alessi, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Alessi,"

Phrase: "D."
Processing 00000000.tx.269: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.270: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.271: Cell Sci. 

Phrase: "Cell Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.272: 114, 29032910[Medline] [OrderarticleviaInfotrieve] Grimes, C. 

Phrase: "114,"

Phrase: "29032910"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Grimes,"

Phrase: "C."
Processing 00000000.tx.273: A., and Jope, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Jope,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.274: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.275: (2001) Prog. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Prog."
Processing 00000000.tx.276: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.277: 65, 391426[CrossRef][Medline] [OrderarticleviaInfotrieve] Schulingkamp, R. 

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "391426"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Schulingkamp,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.278: J., Pagano, T. 

Phrase: "J.,"

Phrase: "Pagano,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.279: C., Hung, D., and Raffa, R. 

Phrase: "C., Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0544691:hang [Injury or Poisoning]
   827   C1823998:HANG [Gene or Genome]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Raffa,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.280: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.281: (2000) Neurosci. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.282: Biobehav. 

Phrase: "Biobehav."
Processing 00000000.tx.283: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.284: 24, 855872[CrossRef][Medline] [OrderarticleviaInfotrieve] Perros, P., and Frier, B. 

Phrase: "24,"

Phrase: "855872"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Perros,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Frier,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.285: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.286: (1997) Horm. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Horm."
Processing 00000000.tx.287: Metab. 

Phrase: "Metab."
Processing 00000000.tx.288: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.289: 29, 197202[Medline] [OrderarticleviaInfotrieve] Parkes, M., and White, K. 

Phrase: "29,"

Phrase: "197202"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Parkes,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.290: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.291: (2000) Behav. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Behav."
Processing 00000000.tx.292: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.293: 114, 307319[CrossRef][Medline] [OrderarticleviaInfotrieve] Messier, C. 

Phrase: "114,"

Phrase: "307319"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Messier, C."
Processing 00000000.tx.294: (2004) Eur. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.295: J. 

Phrase: "J."
Processing 00000000.tx.296: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.297: 490, 3357[CrossRef][Medline] [OrderarticleviaInfotrieve] Bradford, M. 

Phrase: "490,"

Phrase: "3357"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bradford,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.298: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.299: (1976) Anal. 

Phrase: "(1976"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.300: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.301: 41, 248254 Watcharasit, P., Bijur, G. 

Phrase: "41,"

Phrase: "248254 Watcharasit,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bijur,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.302: N., Zmijewski, J. 

Phrase: "N., Zmijewski,"

Phrase: "J."
Processing 00000000.tx.303: W., Song, L., Zmijewska, A., Chen, X., Johnson, G. 

Phrase: "W., Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0872005:Song [Intellectual Product]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Zmijewska,"

Phrase: "A.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "X.,"

Phrase: "Johnson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.304: V. 

Phrase: "V."
Processing 00000000.tx.305: W., and Jope, R. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Jope,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.306: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.307: (2002) Proc. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.308: Natl. 

Phrase: "Natl."
Processing 00000000.tx.309: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.310: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.311: U. 

Phrase: "U."
Processing 00000000.tx.312: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.313: A. 

Phrase: "A."
Processing 00000000.tx.314: 99, 79517955[Abstract/Free FullText] Planel, E., Miyasaka, T., Launey, T., Chui, D. 

Phrase: "99,"

Phrase: "79517955"

Phrase: "[Abstract/Free FullText"

Phrase: "] Planel,"

Phrase: "E.,"

Phrase: "Miyasaka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Launey,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Chui,"

Phrase: "D."
Processing 00000000.tx.315: H., Tanemura, K., Sato, S., Murayama, O., Ishiguro, K., Tatebayashi, Y., and Takashima, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tanemura,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sato,"

Phrase: "S."

Phrase: ","

Phrase: "Murayama,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Ishiguro,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tatebayashi,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Takashima,"

Phrase: "A."
Processing 00000000.tx.316: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.317: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.318: 24, 24012411[Abstract/Free FullText] Shao, J., Yamashita, H., Qiao, L., and Friedman, J. 

Phrase: "24,"

Phrase: "24012411"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shao,"

Phrase: "J.,"

Phrase: "Yamashita,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Qiao,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Friedman,"

Phrase: "J."
Processing 00000000.tx.319: E. 

Phrase: "E."
Processing 00000000.tx.320: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.321: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.322: 167, 107115[Abstract/Free FullText] Schubert, M., Brazil, D. 

Phrase: "167,"

Phrase: "107115"

Phrase: "[Abstract/Free FullText"

Phrase: "] Schubert,"

Phrase: "M."

Phrase: ","

Phrase: "Brazil,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006137:Brazil [Geographic Area]

Phrase: "D."
Processing 00000000.tx.323: P., Burks, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Burks,"

Phrase: "D."
Processing 00000000.tx.324: J., Kushner, J. 

Phrase: "J.,"

Phrase: "Kushner,"

Phrase: "J."
Processing 00000000.tx.325: A., Ye, J., Flint, C. 

Phrase: "A.,"

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "J.,"

Phrase: "Flint,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0303753:Flint [Inorganic Chemical]

Phrase: "C."
Processing 00000000.tx.326: L., Farhang-Fallah, J., Dikkes, P., Warot, X. 

Phrase: "L., Farhang-Fallah,"

Phrase: "J.,"

Phrase: "Dikkes,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Warot,"

Phrase: "X."
Processing 00000000.tx.327: M., Rio, C., Corfas, G., and White, M. 

Phrase: "M."

Phrase: ","

Phrase: "Rio,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445581:Rio [Intellectual Product]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Corfas,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.328: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.329: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.330: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.331: 23, 70847092[Abstract/Free FullText] Withers, D. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "70847092"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "Withers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230107:Withers [Body Part, Organ, or Organ Component]

Phrase: ","

Phrase: "D."
Processing 00000000.tx.332: J., Gutierrez, J. 

Phrase: "J.,"

Phrase: "Gutierrez,"

Phrase: "J."
Processing 00000000.tx.333: S., Towery, H., Burks, D. 

Phrase: "S."

Phrase: ","

Phrase: "Towery,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Burks,"

Phrase: "D."
Processing 00000000.tx.334: J., Ren, J. 

Phrase: "J.,"

Phrase: "Ren,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022646:Ren [Body Part, Organ, or Organ Component]
  1000   C1419338:REN [Gene or Genome]
  1000   C1427479:REN [Gene or Genome]

Phrase: "J."
Processing 00000000.tx.335: M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. 

Phrase: "M."

Phrase: ","

Phrase: "Previs,"

Phrase: "S."

Phrase: ","

Phrase: "Zhang,"

Phrase: "Y.,"

Phrase: "Bernal,"

Phrase: "D."

Phrase: ","

Phrase: "Pons,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0032639:Pons [Body Part, Organ, or Organ Component]
  1000   C1280999:Pons [Body Part, Organ, or Organ Component]
   966 E C1418754:PON [Gene or Genome]
   966 E C1709588:PON [Mammal]

Phrase: "S."

Phrase: ","

Phrase: "Shulman,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.336: I., Bonner-Weir, S., and White, M. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Bonner-Weir,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.337: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.338: (1998) Nature 391, 900904[CrossRef][Medline] [OrderarticleviaInfotrieve] Schubert, M., Gautam, D., Surjo, D., Ueki, K., Stephanie, B., Schubert, D., Kondo, T., Alber, J., Galldiks, N., Kustermann, E., Arndt, S., Jacobs, A. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nature 391,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "900904"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Schubert,"

Phrase: "M."

Phrase: ","

Phrase: "Gautam,"

Phrase: "D."

Phrase: ","

Phrase: "Surjo,"

Phrase: "D."

Phrase: ","

Phrase: "Ueki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Stephanie,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Schubert,"

Phrase: "D."

Phrase: ","

Phrase: "Kondo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Alber,"

Phrase: "J.,"

Phrase: "Galldiks,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kustermann,"

Phrase: "E.,"

Phrase: "Arndt,"

Phrase: "S."

Phrase: ","

Phrase: "Jacobs,"

Phrase: "A."
Processing 00000000.tx.339: H., Krone, W., Kahn, C. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Krone,"

Phrase: "W.,"

Phrase: "Kahn,"

Phrase: "C."
Processing 00000000.tx.340: R., and Bruning, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Bruning,"

Phrase: "J."
Processing 00000000.tx.341: C. 

Phrase: "C."
Processing 00000000.tx.342: (2004) Proc. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.343: Natl. 

Phrase: "Natl."
Processing 00000000.tx.344: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.345: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.346: U. 

Phrase: "U."
Processing 00000000.tx.347: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.348: A. 

Phrase: "A."
Processing 00000000.tx.349: 101, 31003105[Abstract/Free FullText] Ho, L., Qin, W., Pompl, P. 

Phrase: "101,"

Phrase: "31003105"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Qin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812297:QIN [Gene or Genome]
  1000   C1705148:QIN [Gene or Genome]

Phrase: "W.,"

Phrase: "Pompl,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.350: N., Xiang, Z., Wang, J., Zhao, Z., Peng, Y., Cambareri, G., Rocher, A., Mobbs, C. 

Phrase: "N., Xiang,"

Phrase: "Z.,"

Phrase: "Wang,"

Phrase: "J.,"

Phrase: "Zhao,"

Phrase: "Z.,"

Phrase: "Peng,"

Phrase: "Y.,"

Phrase: "Cambareri,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Rocher,"

Phrase: "A.,"

Phrase: "Mobbs,"

Phrase: "C."
Processing 00000000.tx.351: V., Hof, P. 

Phrase: "V., Hof,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1538150:HOF [Gene or Genome]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.352: R., and Pasinetti, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Pasinetti,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.353: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.354: (2004) FASEB J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "FASEB J."
Processing 00000000.tx.355: 18, 902904[Abstract/Free FullText] Eldar-Finkelman, H., Schreyer, S., Shinohara, M., LeBoeuf, R., and Krebs, E. 

Phrase: "18,"

Phrase: "902904"

Phrase: "[Abstract/Free FullText"

Phrase: "] Eldar-Finkelman,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schreyer,"

Phrase: "S."

Phrase: ","

Phrase: "Shinohara,"

Phrase: "M."

Phrase: ","

Phrase: "LeBoeuf,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Krebs,"

Phrase: "E."
Processing 00000000.tx.356: (1999) Diabetes 48, 16621666[Abstract] Semiz, S., Orvig, C., and McNeill, J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Diabetes 48,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "16621666"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Semiz,"

Phrase: "S."

Phrase: ","

Phrase: "Orvig,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "McNeill,"

Phrase: "J."
Processing 00000000.tx.357: (2002) Mol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.358: Cell Biochem. 

Phrase: "Cell Biochem."
Processing 00000000.tx.359: 231, 2335[CrossRef][Medline] [OrderarticleviaInfotrieve] Henriksen, E. 

Phrase: "231,"

Phrase: "2335"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Henriksen,"

Phrase: "E."
Processing 00000000.tx.360: J., Kinnick, T. 

Phrase: "J.,"

Phrase: "Kinnick,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.361: R., Teachey, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Teachey,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.362: K., O'Keefe, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "O'Keefe,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.363: P., Ring, D., and Johnson, K. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ring,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521164:Ring [Spatial Concept]
  1000   C1260969:Ring [Medical Device]
  1000   C1705184:Ring [Medical Device]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Johnson,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.364: W. 

Phrase: "W."
Processing 00000000.tx.365: (2003) Am. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.366: J. 

Phrase: "J."
Processing 00000000.tx.367: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.368: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.369: Metab. 

Phrase: "Metab."
Processing 00000000.tx.370: 284, 892900 Nikoulina, S. 

Phrase: "284,"

Phrase: "892900 Nikoulina,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.371: E., Ciaraldi, T. 

Phrase: "E.,"

Phrase: "Ciaraldi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.372: P., Mudaliar, S., Mohideen, P., Carter, L., and Henry, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Mudaliar,"

Phrase: "S."

Phrase: ","

Phrase: "Mohideen,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Carter,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Henry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582517:henry [Quantitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.373: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.374: (2000) Diabetes 49, 263271[Abstract] Laviola, L., Belsanti, G., Davalli, A. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Diabetes 49,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "263271"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Laviola,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Belsanti,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Davalli,"

Phrase: "A."
Processing 00000000.tx.375: M., Napoli, R., Perrini, S., Weir, G. 

Phrase: "M."

Phrase: ","

Phrase: "Napoli,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Perrini,"

Phrase: "S."

Phrase: ","

Phrase: "Weir,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.376: C., Giorgino, R., and Giorgino, F. 

Phrase: "C., Giorgino,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Giorgino,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.377: (2001) Diabetes 50, 27092720[Abstract/Free FullText] Eldar-Finkelman, H. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Diabetes 50,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "27092720"

Phrase: "[Abstract/Free FullText"

Phrase: "] Eldar-Finkelman,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.378: (2002) Trends Mol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.379: Med. 

Phrase: "Med."
Processing 00000000.tx.380: 8, 126132[CrossRef][Medline] [OrderarticleviaInfotrieve] Pearce, N. 

Phrase: "8,"

Phrase: "126132"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pearce,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.381: J., Arch, J. 

Phrase: "J.,"

Phrase: "Arch,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]

Phrase: "J."
Processing 00000000.tx.382: R., Clapham, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Clapham,"

Phrase: "J."
Processing 00000000.tx.383: C., Coghlan, M. 

Phrase: "C., Coghlan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.384: P., Corcoran, S. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Corcoran,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.385: L., Lister, C. 

Phrase: "L., Lister,"

Phrase: "C."
Processing 00000000.tx.386: A., Llano, A., Moore, G. 

Phrase: "A.,"

Phrase: "Llano,"

Phrase: "A.,"

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.387: B., Murphy, G. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Murphy,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.388: J., Smith, S. 

Phrase: "J.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.389: A., Taylor, C. 

Phrase: "A.,"

Phrase: "Taylor,"

Phrase: "C."
Processing 00000000.tx.390: M., Yates, J. 

Phrase: "M."

Phrase: ","

Phrase: "Yates,"

Phrase: "J."
Processing 00000000.tx.391: W., Morrison, A. 

Phrase: "W., Morrison,"

Phrase: "A."
Processing 00000000.tx.392: D., Harper, A. 

Phrase: "D."

Phrase: ","

Phrase: "Harper,"

Phrase: "A."
Processing 00000000.tx.393: J., Roxbee-Cox, L., Abuin, A., Wargent, E., and Holder, J. 

Phrase: "J.,"

Phrase: "Roxbee-Cox,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Abuin,"

Phrase: "A.,"

Phrase: "Wargent,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Holder,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551377:holder [Manufactured Object]
  1000   C1555310:Holder [Idea or Concept]
  1000   C1706054:Holder [Medical Device]

Phrase: "J."
Processing 00000000.tx.394: C. 

Phrase: "C."
Processing 00000000.tx.395: (2004) Metabolism 53, 13221330[CrossRef][Medline] [OrderarticleviaInfotrieve] Plotkin, B., Kaidanovich, O., Talior, I., and Eldar-Finkelman, H. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Metabolism 53,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "13221330"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Plotkin,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kaidanovich,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Talior,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Eldar-Finkelman,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.396: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.397: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.398: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.399: Ther. 

Phrase: "Ther."
Processing 00000000.tx.400: 305, 974980[Abstract/Free FullText] Smith, S. 

Phrase: "305,"

Phrase: "974980"

Phrase: "[Abstract/Free FullText"

Phrase: "] Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.401: A., Porter, L. 

Phrase: "A.,"

Phrase: "Porter,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0402671:Porter [Professional or Occupational Group]
  1000   C2244327:porter [Molecular Function]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.402: E., Biswas, N., and Freed, M. 

Phrase: "E.,"

Phrase: "Biswas,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Freed,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0332296:free [Functional Concept]
   966   C1880497:Free [Qualitative Concept]
   966   C1996904:Free [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.403: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.404: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.405: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.406: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.407: Metab. 

Phrase: "Metab."
Processing 00000000.tx.408: 89, 60486053[Abstract/Free FullText] Yue, T. 

Phrase: "89,"

Phrase: "60486053"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yue,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.409: L., Bao, W., Gu, J. 

Phrase: "L., Bao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0428597:BAO [Finding]

Phrase: "W.,"

Phrase: "Gu,"

Phrase: "J."
Processing 00000000.tx.410: L., Cui, J., Tao, L., Ma, X. 

Phrase: "L., Cui,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1707476:CUI [Intellectual Product]
   861   C2348662:CUI [Intellectual Product]

Phrase: "J.,"

Phrase: "Tao,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   944   C0041165:Troleandomycin [Antibiotic,Organic Chemical]
   916 E C0040021:taos [Disease or Syndrome]
   916 E C1551534:Taos [Population Group]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Ma,"

Phrase: "X."
Processing 00000000.tx.411: L., Ohlstein, E. 

Phrase: "L., Ohlstein,"

Phrase: "E."
Processing 00000000.tx.412: H., and Jucker, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Jucker,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.413: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.414: (2005) Diabetes 54, 554562[Abstract/Free FullText] Ring, D. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Diabetes 54,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "554562"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ring,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521164:Ring [Spatial Concept]
  1000   C1260969:Ring [Medical Device]
  1000   C1705184:Ring [Medical Device]

Phrase: "D."
Processing 00000000.tx.415: B., Johnson, K. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Johnson,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.416: W., Henriksen, E. 

Phrase: "W., Henriksen,"

Phrase: "E."
Processing 00000000.tx.417: J., Nuss, J. 

Phrase: "J.,"

Phrase: "Nuss,"

Phrase: "J."
Processing 00000000.tx.418: M., Goff, D., Kinnick, T. 

Phrase: "M."

Phrase: ","

Phrase: "Goff,"

Phrase: "D."

Phrase: ","

Phrase: "Kinnick,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.419: R., Ma, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ma,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.420: T., Reeder, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Reeder,"

Phrase: "J."
Processing 00000000.tx.421: W., Samuels, I., Slabiak, T., Wagman, A. 

Phrase: "W., Samuels,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Slabiak,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Wagman,"

Phrase: "A."
Processing 00000000.tx.422: S., Hammond, M. 

Phrase: "S."

Phrase: ","

Phrase: "Hammond,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.423: E., and Harrison, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Harrison,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.424: D. 

Phrase: "D."
Processing 00000000.tx.425: (2003) Diabetes 52, 588595[Abstract/Free FullText] Cline, G. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Diabetes 52,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "588595"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cline,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.426: W., Johnson, K., Regittnig, W., Perret, P., Tozzo, E., Xiao, L., and Damico, C. 

Phrase: "W., Johnson,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Regittnig,"

Phrase: "W.,"

Phrase: "Perret,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Tozzo,"

Phrase: "E.,"

Phrase: "Xiao,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Damico,"

Phrase: "C."
Processing 00000000.tx.427: (2002) Diabetes 51, 29032910[Abstract/Free FullText] Jope, R. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Diabetes 51,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "29032910"

Phrase: "[Abstract/Free FullText"

Phrase: "] Jope,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.428: S., and Johnson, G. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Johnson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.429: V. 

Phrase: "V."
Processing 00000000.tx.430: W. 

Phrase: "W."
Processing 00000000.tx.431: (2004) Trends Biochem. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.432: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.433: 29, 95102[CrossRef][Medline] [OrderarticleviaInfotrieve] Jope, R. 

Phrase: "29,"

Phrase: "95102"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Jope,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.434: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.435: (2003) Trends Pharmacol. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Pharmacol."
Processing 00000000.tx.436: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.437: 24, 441443[CrossRef][Medline] [OrderarticleviaInfotrieve] Li, X., Zhu, W., Roh, M. 

Phrase: "24,"

Phrase: "441443"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "X.,"

Phrase: "Zhu,"

Phrase: "W.,"

Phrase: "Roh,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.438: S., Friedman, A. 

Phrase: "S."

Phrase: ","

Phrase: "Friedman,"

Phrase: "A."
Processing 00000000.tx.439: B., Rosborough, K., and Jope, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Rosborough,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Jope,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.440: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.441: (2004) Neuropsychopharmacology 29, 14261431[CrossRef][Medline] [OrderarticleviaInfotrieve]

Phrase: "(2004"

Phrase: ")"

Phrase: "Neuropsychopharmacology 29,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1537034:neuropsychopharmacology [Biomedical Occupation or Discipline]

Phrase: "14261431"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

